##fileformat=VCFv4.2
##fileDate=20250331
##source=ScriptPython
##reference=GRCh37
##INFO=<ID=PHENOTYPE,Number=.,Type=String,Description="Disease phenotype">
##INFO=<ID=INTERPRETATION,Number=.,Type=String,Description="Variant interpretation">
##INFO=<ID=INTERPRETATION_REASON,Number=.,Type=String,Description="Reason for interpretation">
##INFO=<ID=CLINICAL_ACTIONABILITY,Number=.,Type=String,Description="Clinical actionability">
##INFO=<ID=GENE,Number=.,Type=String,Description="Gene symbol">
##INFO=<ID=VARIANT_ID,Number=1,Type=String,Description="Variant identifier">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
14	23896866	VCV003721471	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003721471
14	23901907	VCV003338333	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003338333
14	23901907	VCV003338333	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003338333
14	23895233	VCV002736085	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002736085
14	23901923	VCV002574111	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002574111
14	23901923	VCV002574111	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002574111
14	23901923	VCV002574111	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002574111
14	23900885	VCV002506164	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002506164
14	23891521	VCV002137559	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002137559
14	23891521	VCV002137559	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002137559
14	23889128	VCV002137557	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002137557
14	23899785	VCV001803142	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV001803142
14	23899785	VCV001803142	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV001803142
14	23894176	VCV001791933	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV001791933
14	23894189	VCV001791718	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV001791718
14	23896934	rs2138672244A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138672244A
14	23896934	rs2138672244A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138672244A
14	23894192	rs1373092362G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1373092362G
14	23894192	rs1373092362G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1373092362G
14	23894525	rs3218716G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs3218716G
14	23894525	rs3218716G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs3218716G
14	23898223	rs1403027088C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1403027088C
14	23898267	rs1484300349G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1484300349G
14	23893324	rs730880757A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880757A
14	23893324	rs730880757A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880757A
14	23895200	rs1224554825A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1224554825A
14	23895200	rs1224554825A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1224554825A
14	23894121	rs730880748T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880748T
14	23894121	rs730880748T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880748T
14	23898479	rs1422611896T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1422611896T
14	23898479	rs1422611896T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1422611896T
14	23900208	rs2138680281C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138680281C
14	23888757	rs758889483T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs758889483T
14	23894027	rs1282663873T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1282663873T
14	23894027	rs1282663873T	A	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1282663873T
14	23896053	rs1241603111T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1241603111T
14	23896053	rs1241603111T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1241603111T
14	23894998	rs1247313340A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1247313340A
14	23894998	rs1247313340A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1247313340A
14	23894153	rs876657880G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs876657880G
14	23894153	rs876657880G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs876657880G
14	23896043	rs397516127T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516127T
14	23896043	rs397516127T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516127T
14	23886521	rs1358268382T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs1358268382T
14	23900871	rs1892947729C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892947729C
14	23900871	rs1892947729C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892947729C
14	23895189	rs121913638G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913638G
14	23895189	rs121913638G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913638G
14	23887548	rs778542758C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs778542758C
14	23891500	rs397516178T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516178T
14	23891500	rs397516178T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516178T
14	23891500	rs397516178T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516178T
14	23894990	rs1173617248C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1173617248C
14	23894990	rs1173617248C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1173617248C
14	23898532	rs1595087175G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1595087175G
14	23894187	rs397516149T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516149T
14	23902781	rs397516117A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516117A
14	23894528	rs1222361739A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1222361739A
14	23894528	rs1222361739A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1222361739A
14	23894528	rs1222361739A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1222361739A
14	23893181	rs1391622163G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1391622163G
14	23893181	rs1391622163G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1391622163G
14	23896881	rs1131691685A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1131691685A
14	23896881	rs1131691685A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1131691685A
14	23885503	rs727505176T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs727505176T
14	23887588	rs1238061743A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1238061743A
14	23894193	rs730880742C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880742C
14	23894193	rs730880742C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880742C
14	23894063	rs758891557C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs758891557C
14	23894063	rs758891557C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs758891557C
14	23894063	rs758891557C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs758891557C
14	23894084	rs2856897G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2856897G
14	23894084	rs2856897G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2856897G
14	23891464	rs1298412196T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1298412196T
14	23882979	rs767300277A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs767300277A
14	23894581	rs121913634A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913634A
14	23894581	rs121913634A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913634A
14	23894581	rs121913634A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913634A
14	23900880	rs772488436C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs772488436C
14	23893247	rs1131691514T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1131691514T
14	23893247	rs1131691514T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1131691514T
14	23884304	rs371855540T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs371855540T
14	23884304	rs371855540T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs371855540T
14	23900862	rs1060501445T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1060501445T
14	23897743	rs863224900C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863224900C
14	23897743	rs863224900C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863224900C
14	23894024	rs1060501436G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060501436G
14	23894024	rs1060501436G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060501436G
14	23894109	rs1060499880T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060499880T
14	23902931	rs758659692A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs758659692A
14	23900850	rs1057517773T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1057517773T
14	23900850	rs1057517773T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1057517773T
14	23901048	rs1057517772C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1057517772C
14	23901865	rs1057517771C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1057517771C
14	23894580	rs2069544C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2069544C
14	23894580	rs2069544C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2069544C
14	23894569	rs886039185T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs886039185T
14	23894569	rs886039185T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs886039185T
14	23893156	rs727504374C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504374C
14	23895254	rs886039030T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs886039030T
14	23895254	rs886039030T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs886039030T
14	23895254	rs886039030T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs886039030T
14	23893991	rs886038813T	A	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs886038813T
14	23898551	rs878853836A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs878853836A
14	23898213	rs397516101A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516101A
14	23898213	rs397516101A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516101A
14	23902905	rs759231966T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs759231966T
14	23889158	rs730880781T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880781T
14	23889158	rs730880781T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880781T
14	23893145	rs863225100T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225100T
14	23893145	rs863225100T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225100T
14	23894989	rs863225097G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225097G
14	23894989	rs863225097G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225097G
14	23895179	rs121913641G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913641G
14	23895179	rs121913641G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913641G
14	23895179	rs121913641G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913641G
14	23897743	rs863224900G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863224900G
14	23897743	rs863224900G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863224900G
14	23897743	rs863224900G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863224900G
14	23894965	rs786205907T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs786205907T
14	23901053	rs786205906G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs786205906G
14	23901688	rs752930302A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs752930302A
14	23882972	rs730880918A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880918A
14	23887444	rs730880910A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880910A
14	23893255	rs727504558A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504558A
14	23893255	rs727504558A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504558A
14	23894536	rs730880896T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880896T
14	23894536	rs730880896T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880896T
14	23896877	rs730880880C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880880C
14	23896877	rs730880880C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880880C
14	23897001	rs730880878T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880878T
14	23898240	rs730880159C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880159C
14	23898240	rs730880159C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880159C
14	23898464	rs730880868T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880868T
14	23898464	rs730880868T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880868T
14	23898464	rs730880868T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880868T
14	23898485	rs730880867T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880867T
14	23899071	rs730880864C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880864C
14	23900634	rs730880855C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880855C
14	23900634	rs730880855C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880855C
14	23900647	rs730880854T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880854T
14	23900829	rs730880848A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880848A
14	23893234	rs730880761A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880761A
14	23893246	rs730880760C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880760C
14	23893277	rs730880759T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880759T
14	23893277	rs730880759T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880759T
14	23893331	rs730880756T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880756T
14	23893331	rs730880756T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880756T
14	23893331	rs730880756T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880756T
14	23894052	rs730880750A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880750A
14	23894052	rs730880750A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880750A
14	23894052	rs730880750A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880750A
14	23894121	rs730880748G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880748G
14	23894121	rs730880748G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880748G
14	23894568	rs730880736T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880736T
14	23894568	rs730880736T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880736T
14	23894612	rs727503260G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503260G
14	23894612	rs727503260G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503260G
14	23894626	rs730880735C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880735C
14	23894626	rs730880735C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880735C
14	23894961	rs397516139G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC MIDVENTRICULAR DIGENIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516139G
14	23894961	rs397516139G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516139G
14	23895248	rs730880732C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880732C
14	23895248	rs730880732C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880732C
14	23895248	rs730880732C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880732C
14	23894566	rs397516142T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516142T
14	23894566	rs397516142T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516142T
14	23898502	rs730880158T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880158T
14	23901077	rs730880156T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880156T
14	23884594	rs727505294A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs727505294A
14	23884594	rs727505294A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs727505294A
14	23889167	rs727505026T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727505026T
14	23889167	rs727505026T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727505026T
14	23896856	rs727504925C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504925C
14	23896856	rs727504925C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504925C
14	23898247	rs148808089A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs148808089A
14	23898247	rs148808089A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs148808089A
14	23898247	rs148808089A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs148808089A
14	23894055	rs727504356G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504356G
14	23894055	rs727504356G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504356G
14	23894055	rs727504356G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504356G
14	23894055	rs727504356G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504356G
14	23884476	rs727504355T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs727504355T
14	23891398	rs727504342T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504342T
14	23894118	rs727504310C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504310C
14	23894118	rs727504310C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504310C
14	23894118	rs727504310C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504310C
14	23894118	rs727504310C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504310C
14	23891501	rs45611033A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45611033A
14	23891501	rs45611033A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45611033A
14	23884434	rs200939753T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs200939753T
14	23884434	rs200939753T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs200939753T
14	23894084	rs2856897T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2856897T
14	23897788	rs727504286G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504286G
14	23897788	rs727504286G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504286G
14	23889434	rs727504274T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504274T
14	23889434	rs727504274T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504274T
14	23900990	rs727504273G	T	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504273G
14	23900990	rs727504273G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504273G
14	23900990	rs727504273G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504273G
14	23894051	rs202141173T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs202141173T
14	23894051	rs202141173T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs202141173T
14	23894051	rs202141173T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs202141173T
14	23894051	rs202141173T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs202141173T
14	23894969	rs121913632A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632A
14	23894969	rs121913632A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632A
14	23894969	rs121913632A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632A
14	23893330	rs727504261C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504261C
14	23893330	rs727504261C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504261C
14	23894627	rs727504253T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504253T
14	23884437	rs369437262C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs369437262C
14	23894992	rs727504241T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504241T
14	23895255	rs727504240A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504240A
14	23895255	rs727504240A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504240A
14	23895255	rs727504240A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504240A
14	23896451	rs727504239C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504239C
14	23896451	rs727504239C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504239C
14	23896451	rs727504239C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504239C
14	23896451	rs727504239C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504239C
14	23896955	rs727504238C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504238C
14	23896955	rs727504238C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504238C
14	23896955	rs727504238C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504238C
14	23897738	rs727504237T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504237T
14	23897738	rs727504237T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504237T
14	23897851	rs727504236C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504236C
14	23897851	rs727504236C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504236C
14	23901923	rs727503278A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503278A
14	23901923	rs727503278A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503278A
14	23901923	rs727503278A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503278A
14	23901923	rs727503278A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503278A
14	23900977	rs727503277A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503277A
14	23900684	rs727503276G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503276G
14	23900684	rs727503276G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503276G
14	23898288	rs727503266A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503266A
14	23896019	rs727503263A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503263A
14	23896019	rs727503263A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503263A
14	23896019	rs727503263A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503263A
14	23894983	rs727503261G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503261G
14	23894983	rs727503261G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503261G
14	23894983	rs727503261G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503261G
14	23894612	rs727503260T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503260T
14	23894612	rs727503260T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503260T
14	23894612	rs727503260T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503260T
14	23894085	rs2754158A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2754158A
14	23894085	rs2754158A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2754158A
14	23894085	rs2754158A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2754158A
14	23893256	rs727503252T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503252T
14	23893256	rs727503252T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503252T
14	23893250	rs397516171G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516171G
14	23893250	rs397516171G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516171G
14	23893250	rs397516171G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516171G
14	23887522	rs727503246T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503246T
14	23887522	rs727503246T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503246T
14	23884256	rs727503242A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503242A
14	23899810	rs376897125T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs376897125T
14	23899810	rs376897125T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs376897125T
14	23899810	rs376897125T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs376897125T
14	23899810	rs376897125T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs376897125T
14	23894049	rs138049878A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs138049878A
14	23894049	rs138049878A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs138049878A
14	23894049	rs138049878A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs138049878A
14	23894049	rs138049878A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs138049878A
14	23887536	rs370403289A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs370403289A
14	23884458	rs139222507T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs139222507T
14	23884227	rs12590294A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs12590294A
14	23883310	rs372381770A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs372381770A
14	23899792	rs372731424G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs372731424G
14	23900635	rs397516269G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516269G
14	23900635	rs397516269G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516269G
14	23900635	rs397516269G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516269G
14	23900635	rs397516269G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516269G
14	23900799	rs397516265A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516265A
14	23900799	rs397516265A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516265A
14	23900998	rs397516260T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516260T
14	23900998	rs397516260T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516260T
14	23900998	rs397516260T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516260T
14	23884461	rs397516241T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs397516241T
14	23885041	rs397516233A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs397516233A
14	23885257	rs141122361T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs141122361T
14	23886184	rs397516222A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516222A
14	23886394	rs397516218G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516218G
14	23886394	rs397516218G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516218G
14	23886409	rs3729823C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs3729823C
14	23901912	rs397516212A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516212A
14	23901912	rs397516212A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516212A
14	23886504	rs201307101A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs201307101A
14	23886504	rs201307101A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs201307101A
14	23886717	rs397516211T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516211T
14	23886717	rs397516211T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516211T
14	23901922	rs397516209T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209T
14	23901922	rs397516209T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209T
14	23901922	rs397516209T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209T
14	23901922	rs397516209T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209T
14	23886806	rs397516207T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516207T
14	23886806	rs397516207T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516207T
14	23886806	rs397516207T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516207T
14	23886807	rs145213771A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs145213771A
14	23886807	rs145213771A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs145213771A
14	23886807	rs145213771A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs145213771A
14	23887453	rs397516202T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516202T
14	23887453	rs397516202T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516202T
14	23887453	rs397516202T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516202T
14	23887453	rs397516202T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516202T
14	23887458	rs397516201A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516201A
14	23887458	rs397516201A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516201A
14	23887458	rs397516201A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516201A
14	23887458	rs397516201A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516201A
14	23887606	rs372727092T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs372727092T
14	23902295	rs397516183G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516183G
14	23891465	rs397516179T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516179T
14	23891465	rs397516179T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516179T
14	23891481	rs45540831T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45540831T
14	23892910	rs145532615G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs145532615G
14	23893250	rs397516171T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516171T
14	23893250	rs397516171T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516171T
14	23893259	rs397516170T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516170T
14	23893259	rs397516170T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516170T
14	23893357	rs397516161C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516161C
14	23893357	rs397516161C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516161C
14	23894013	rs397516160C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516160C
14	23894013	rs397516160C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516160C
14	23894013	rs397516160C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516160C
14	23894102	rs397516157G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516157G
14	23894102	rs397516157G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516157G
14	23894102	rs397516157G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516157G
14	23894111	rs397516156G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516156G
14	23894111	rs397516156G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516156G
14	23894525	rs3218716T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs3218716T
14	23894525	rs3218716T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs3218716T
14	23894554	rs376754645T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs376754645T
14	23894969	rs121913632T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632T
14	23894969	rs121913632T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632T
14	23895023	rs121913630C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630C
14	23895023	rs121913630C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630C
14	23895023	rs121913630C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630C
14	23895023	rs121913630C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630C
14	23895242	rs397516130G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516130G
14	23895242	rs397516130G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516130G
14	23896042	rs371898076T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs371898076T
14	23896042	rs371898076T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs371898076T
14	23896042	rs371898076T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs371898076T
14	23896042	rs371898076T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs371898076T
14	23896043	rs397516127A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516127A
14	23896043	rs397516127A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516127A
14	23896043	rs397516127A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516127A
14	23896043	rs397516127A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516127A
14	23896932	rs121913626T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626T
14	23896932	rs121913626T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626T
14	23896932	rs121913626T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626T
14	23896932	rs121913626T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626T
14	23897755	rs397516110G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516110G
14	23897755	rs397516110G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516110G
14	23897755	rs397516110G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516110G
14	23898201	rs397516103G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516103G
14	23898201	rs397516103G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516103G
14	23898201	rs397516103G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516103G
14	23898201	rs397516103G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516103G
14	23898213	rs397516101T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516101T
14	23898213	rs397516101T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516101T
14	23898213	rs397516101T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516101T
14	23898213	rs397516101T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516101T
14	23898253	rs397516098T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516098T
14	23898253	rs397516098T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516098T
14	23898298	rs397516097T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516097T
14	23898298	rs397516097T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516097T
14	23898298	rs397516097T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516097T
14	23898475	rs397516095A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516095A
14	23898475	rs397516095A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516095A
14	23902827	rs376160714T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs376160714T
14	23899059	rs397516088T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516088T
14	23899059	rs397516088T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516088T
14	23899059	rs397516088T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516088T
14	23902865	rs186964570A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs186964570A
14	23884860	rs193922390T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,LOC126861897,MYH7;VARIANT_ID=rs193922390T
14	23884860	rs193922390T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,LOC126861897,MYH7;VARIANT_ID=rs193922390T
14	23884860	rs193922390T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,LOC126861897,MYH7;VARIANT_ID=rs193922390T
14	23884860	rs193922390T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,LOC126861897,MYH7;VARIANT_ID=rs193922390T
14	23887607	rs141764279T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs141764279T
14	23898214	rs121913625T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913625T
14	23898214	rs121913625T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913625T
14	23898214	rs121913625T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913625T
14	23900798	rs267606910T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606910T
14	23900798	rs267606910T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606910T
14	23900798	rs267606910T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606910T
14	23893321	rs267606908C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606908C
14	23893321	rs267606908C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606908C
14	23893321	rs267606908C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606908C
14	23897796	rs267606911A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606911A
14	23897796	rs267606911A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606911A
14	23897796	rs267606911A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs267606911A
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs36211715T
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs36211715T
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs36211715T
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs36211715T
14	23897840	rs121913651T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913651T
14	23897840	rs121913651T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913651T
14	23897840	rs121913651T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913651T
14	23884861	rs121913650A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs121913650A
14	23884861	rs121913650A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs121913650A
14	23884861	rs121913650A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs121913650A
14	23884861	rs121913650A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs121913650A
14	23895007	rs121913644A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913644A
14	23895179	rs121913641T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913641T
14	23895179	rs121913641T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913641T
14	23893235	rs121913639T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913639T
14	23893235	rs121913639T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913639T
14	23893235	rs121913639T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913639T
14	23895189	rs121913638T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913638T
14	23895189	rs121913638T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913638T
14	23895189	rs121913638T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913638T
14	23895180	rs121913637A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913637A
14	23895180	rs121913637A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913637A
14	23895180	rs121913637A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913637A
14	23895180	rs121913637A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913637A
14	23897749	rs121913636C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913636C
14	23897749	rs121913636C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913636C
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898487	rs121913624A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624A
14	23898487	rs121913624A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624A
14	23898487	rs121913624A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624A
14	23894581	rs121913634C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913634C
14	23894581	rs121913634C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913634C
14	23894581	rs121913634C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913634C
14	23900656	rs121913633T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913633T
14	23900656	rs121913633T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913633T
14	23894969	rs121913632G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632G
14	23894969	rs121913632G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913632G
14	23893316	rs121913631C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913631C
14	23893316	rs121913631C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913631C
14	23893316	rs121913631C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913631C
14	23893316	rs121913631C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913631C
14	23895023	rs121913630A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630A
14	23895023	rs121913630A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630A
14	23895023	rs121913630A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913630A
14	23893193	rs121913629T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913629T
14	23893193	rs121913629T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913629T
14	23893193	rs121913629T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913629T
14	23893268	rs121913628T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913628T
14	23893268	rs121913628T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913628T
14	23896866	rs121913627T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913627T
14	23896866	rs121913627T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913627T
14	23896866	rs121913627T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913627T
14	23896932	rs121913626G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626G
14	23896932	rs121913626G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626G
14	23896932	rs121913626G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626G
14	23898214	rs121913625A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913625A
14	23898214	rs121913625A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913625A
14	23898214	rs121913625A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913625A
14	23900677	rs3218713T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713T
14	23900677	rs3218713T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713T
14	23898487	rs121913624T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624T
14	23898487	rs121913624T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624T
14	23898487	rs121913624T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624T
14	23898487	rs121913624T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913624T
14	23885373	VCV003773698	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=VCV003773698
14	23885373	VCV003773698	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=VCV003773698
11	47362584	VCV003773673	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003773673
11	47364149	VCV003767994	AGC	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003767994
6	74201988	VCV003767215	G	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003767215
2	179430047	VCV003764732	GCAA	TGAGGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003764732
2	179477654	VCV003764683	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003764683
11	19213968	VCV003764079	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV003764079
7	128480130	VCV003763453	GTTCGCGT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003763453
11	19207762	VCV003763020	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV003763020
7	128494696	VCV003760452	CGGAGGCACAGGGCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=VCV003760452
7	128489445	VCV003760368	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003760368
7	128483316	VCV003760362	G	GAC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003760362
7	128489477	VCV003760037	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003760037
7	128480698	VCV003760035	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003760035
7	128478413	VCV003759997	C	CCACG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003759997
7	128496878	VCV003759912	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003759912
7	128480200	VCV003759871	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003759871
11	19213942	VCV003759643	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV003759643
7	128481563	VCV003759462	CTGAGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003759462
7	128490978	VCV003759443	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003759443
7	128482893	VCV003759388	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003759388
7	128494194	VCV003759317	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003759317
7	128478416	VCV003759316	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003759316
7	128498159	VCV003758874	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003758874
7	128480901	VCV003758838	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003758838
7	128491573	VCV003758610	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003758610
7	128477313	VCV003757973	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003757973
7	128482390	VCV003757761	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003757761
7	128486458	VCV003757620	CGGGCCAGGCCTGGA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003757620
7	128471044	VCV003757506	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003757506
7	128494697	VCV003757391	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003757391
17	37822010	VCV003757356	A	AC	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV003757356
17	37822010	VCV003757356	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV003757356
7	128470971	VCV003757055	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003757055
7	128483375	VCV003756955	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003756955
7	128498220	VCV003756207	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003756207
7	128482430	VCV003756141	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003756141
7	128492880	VCV003756047	AGG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003756047
7	128470800	VCV003755992	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003755992
7	128481288	VCV003755988	C	CGATG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003755988
11	19207872	VCV003755823	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV003755823
7	128497328	VCV003755381	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003755381
7	128488772	VCV003755344	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003755344
7	128478840	VCV003755175	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003755175
7	128480704	VCV003754761	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003754761
7	128477702	VCV003754759	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003754759
7	128486471	VCV003754391	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003754391
1	201334741	rs730881098C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881098C
1	201334420	VCV003753582	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV003753582
7	128491364	VCV003753518	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003753518
7	128483374	VCV003753413	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003753413
7	128470792	VCV003753027	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003753027
7	128470808	VCV003752852	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003752852
11	19206562	VCV003752686	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV003752686
7	128490101	VCV003752314	CCGGCCCGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003752314
17	37821613	VCV003752172	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV003752172
17	37821613	VCV003752172	A	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV003752172
1	78392124	VCV003751520	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV003751520
7	128493653	VCV003751115	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003751115
7	128481009	VCV003750995	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003750995
7	128489475	VCV003750981	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003750981
7	128491518	VCV003750822	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003750822
1	78392298	VCV003748873	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV003748873
7	128480705	VCV003748720	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003748720
11	47364169	VCV003729197	G	GCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003729197
11	47369457	VCV003725737	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003725737
6	74183330	VCV003725051	AATCC	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003725051
19	55667571	VCV003723680	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV003723680
6	74171746	VCV003723470	C	CG	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003723470
11	47371324	rs730880621A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880621A
11	47353703	VCV003722954	GGGCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003722954
11	47371349	VCV003722943	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003722943
11	47373017	VCV003722941	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003722941
11	47372892	VCV003722513	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003722513
19	55665400	VCV003722249	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV003722249
11	47363673	VCV003722064	G	GTCTGCGATGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003722064
11	47364246	VCV003721976	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003721976
11	47364488	VCV003721775	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003721775
11	47364418	VCV003721532	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003721532
11	47372971	VCV003721027	T	TCCTGCCCGCTC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003721027
11	47365055	VCV003721026	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003721026
11	47364479	VCV003721025	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003721025
11	47355514	VCV003717226	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003717226
19	55667695	VCV003716789	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV003716789
19	55668467	VCV003706410	CTGAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV003706410
11	47371661	VCV003705799	ACCCTGTGAGCAAAGGCTTTTTCTGTTTGTTTGAGATGGAGTCTTGCTCTGTCACCCAGGCTGGAGTGCAGAGGCACAATCTCGGCTCACTGCAAGCTCCGCCTCCCAGGTTCACACCATTCTCCTGCCTCAGCCTCCCAAGTTAGCTGGGACCGCAGGTGCCCGCCACCACGCCCGGCTAATTTTTTTGTATTTTTAGTAGAGATGGGGTTTCATCATGTTAGCCAGGATGGTCTCAATCTCCTGACCTCATGATCCGCCCACCTCGGCCTCCCAAAGTACTGGGGATTATAGGCCTGAGCCACCGCACCTGGCCCAGCAAAGGCTTTTGAGACCTGCCCTGGACACGCCCTACCCACGGATCCTGCCCCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003705799
19	55665575	VCV003703833	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV003703833
6	74175968	VCV003692083	GA	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003692083
11	47372168	VCV003681967	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003681967
11	47359239	VCV003677107	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003677107
6	74189759	VCV003675344	CAG	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003675344
11	47364459	VCV003663028	AAGGGGCGCGTGATGAGCAC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003663028
11	47373044	VCV003660780	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003660780
6	74183236	VCV003659737	AG	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003659737
11	47354402	VCV003659117	C	CGCTCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003659117
11	47354518	VCV003658980	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003658980
11	47353741	VCV003658607	CTTGCTGA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003658607
11	47362744	VCV003658412	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003658412
11	47356661	VCV003658271	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003658271
11	47357451	VCV003657328	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003657328
11	47357505	VCV003654254	G	GA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003654254
11	47359128	VCV003653100	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003653100
11	47372886	VCV003650474	G	GCGTATGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003650474
11	47363625	VCV003642726	TGA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003642726
11	47370001	VCV003641840	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003641840
11	47363541	VCV003638614	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003638614
14	23900668	VCV003636054	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003636054
14	23898476	VCV003636048	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003636048
14	23891521	VCV003636025	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003636025
14	23884995	VCV003636001	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=VCV003636001
11	47372106	VCV003629563	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003629563
11	47355118	VCV003613678	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003613678
14	23889157	VCV003609691	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003609691
14	23900191	VCV003602761	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003602761
7	151273499	VCV003594434	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=VCV003594434
7	128494035	VCV003594297	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV003594297
7	128478798	VCV003594295	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003594295
2	179664213	VCV003585094	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003585094
2	179587792	VCV003585088	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003585088
2	179424269	VCV003585064	A	ACACTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003585064
2	179422474	VCV003585062	TCAGTTTCATGACTTTCATCATGGTTCTTGCAACTGTTGCAGAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003585062
11	47364443	VCV003572899	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003572899
11	47364443	VCV003572899	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003572899
11	47369971	VCV003572875	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003572875
7	150645531	rs1801002279A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=KCNH2;VARIANT_ID=rs1801002279A
7	128477213	VCV003544411	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003544411
7	151433067	VCV003544408	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=VCV003544408
11	47363576	VCV003400427	G	GCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003400427
11	47360164	VCV003400419	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003400419
6	74192298	VCV003399615	T	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003399615
6	74191857	VCV003393476	ATGACCTCACT	TTACATAGGAGTCTTGATTGTTACATAGGAGTCTTGATTGATG	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003393476
11	47358949	VCV003391174	C	TAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003391174
11	47369196	VCV003387141	GGGTACCTGATCCGCCGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003387141
11	47360182	VCV003387118	GGT	CCCG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003387118
11	47359110	VCV003387113	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003387113
11	47355168	VCV003387098	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003387098
11	47354364	VCV003387091	CCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003387091
7	128491297	VCV003383178	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=VCV003383178
2	179480489	VCV003382825	TTCTAGAT	ATCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382825
2	179621204	VCV003382819	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382819
2	179447737	VCV003382785	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382785
7	128486942	VCV003382769	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003382769
2	179539790	VCV003382759	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382759
2	179465590	VCV003382758	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382758
7	128489570	VCV003382750	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003382750
2	179469028	VCV003382748	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382748
2	179455738	VCV003382742	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382742
2	179604536	VCV003382734	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382734
2	179444349	VCV003382691	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806423,TTN,TTN-AS1;VARIANT_ID=VCV003382691
15	35084333	VCV003382680	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=VCV003382680
2	179498775	VCV003382669	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382669
2	179397542	VCV003382663	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382663
2	179621384	VCV003382654	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382654
11	47354401	VCV003382647	CCGCTCTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003382647
2	179472539	VCV003382644	G	GTGTT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806425,TTN,TTN-AS1;VARIANT_ID=VCV003382644
2	179584764	VCV003382642	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382642
2	179559599	VCV003382492	CTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382492
11	47367885	VCV003382478	CACGTCCTCCTCTGCTGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003382478
2	179424630	VCV003382429	C	CTT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382429
2	179477690	VCV003382367	A	ATTAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382367
11	47353727	VCV003382362	G	GTC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003382362
7	128486043	VCV003382351	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003382351
2	179497731	VCV003382273	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382273
2	179485861	VCV003382160	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806427,TTN;VARIANT_ID=VCV003382160
2	179544690	VCV003382129	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003382129
11	47372973	VCV003382080	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003382080
7	128477768	VCV003382075	G	GTGCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003382075
2	179479303	VCV003382061	TTCTTAGGG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806426,TTN,TTN-AS1;VARIANT_ID=VCV003382061
2	179484836	VCV003382006	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003382006
2	179404188	VCV003381978	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003381978
2	179444757	VCV003381972	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003381972
2	179455164	VCV003381946	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003381946
2	179410223	VCV003381936	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003381936
11	47355268	VCV003377518	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003377518
11	47372922	VCV003377500	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003377500
11	47359346	VCV003377189	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003377189
11	47356755	VCV003376852	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376852
11	47373023	VCV003376707	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376707
11	47364846	VCV003376675	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376675
11	47362217	VCV003376667	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376667
14	23898551	VCV003376659	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003376659
11	47362731	VCV003376641	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376641
11	47360072	VCV003376583	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376583
11	47359291	VCV003376568	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003376568
11	47360964	VCV003370308	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003370308
11	47360964	VCV003370308	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003370308
14	23854252	VCV003366965	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 14;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH6;VARIANT_ID=VCV003366965
11	47369991	VCV003366932	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003366932
11	47369991	VCV003366932	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003366932
11	47371563	VCV003362864	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003362864
7	128488676	VCV003362745	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003362745
14	23900792	VCV003354701	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003354701
11	47355138	VCV003341466	CCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003341466
11	47359348	VCV003340524	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003340524
11	47359348	VCV003340524	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003340524
2	179480099	VCV003340517	TAT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV003340517
14	23900798	VCV003338334	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003338334
14	23901013	VCV003297521	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003297521
11	47367819	VCV003297222	AGTGACGCC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003297222
11	47372970	VCV003297215	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003297215
7	128478484	VCV003279225	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003279225
7	128478048	VCV003258072	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003258072
11	47365164	VCV003257731	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003257731
11	47353641	VCV003256566	ACTCACACCGTGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003256566
14	23893345	VCV003253622	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003253622
20	33583250	VCV003251994	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=VCV003251994
6	74189435	VCV003246031	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003246031
6	74171578	VCV003246030	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV003246030
7	128494167	VCV003245795	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ATP6V1F,FLNC,KCP;VARIANT_ID=VCV003245795
7	128470692	VCV003245794	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ATP6V1F,FLNC,IRF5,KCP,TNPO3;VARIANT_ID=VCV003245794
11	18418390	VCV003244681	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3,IGSF22,LDHA,LDHAL6A,LDHC,MRGPRX1,MRGPRX2,PTPN5,SPTY2D1,TMEM86A,TSG101,UEVLD,ZDHHC13;VARIANT_ID=VCV003244681
11	47362521	VCV003244531	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244531
11	47358759	VCV003244529	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244529
11	47353422	VCV003244525	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244525
11	47353422	VCV003244524	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244524
11	47360051	VCV003244523	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244523
11	47368957	VCV003244522	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244522
11	47369975	VCV003244521	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003244521
11	47353422	VCV003244520	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3,SLC39A13,SPI1;VARIANT_ID=VCV003244520
14	23897769	VCV003243939	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003243939
14	23885222	VCV003242432	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MIR208B,MYH7;VARIANT_ID=VCV003242432
14	23891501	VCV003242034	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV003242034
X	None	VCV003236837	None	None	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=DMD;VARIANT_ID=VCV003236837
2	179485354	VCV003236158	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV003236158
7	128489480	VCV003221735	T	TC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV003221735
11	47359286	VCV003076034	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003076034
11	47355301	VCV003076026	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003076026
11	47372941	VCV003075925	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003075925
11	47372942	VCV003075924	C	CCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003075924
11	47361219	VCV003075779	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003075779
14	23894028	VCV003075668	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV003075668
11	47355107	VCV003072403	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV003072403
14	23894084	rs2856897A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2856897A
11	47371665	VCV002971865	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002971865
7	128481236	VCV002954520	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002954520
7	128489616	VCV002954457	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002954457
7	128487999	VCV002954439	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002954439
7	128470988	VCV002954117	C	CGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002954117
7	128471044	VCV002953976	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002953976
7	128475446	VCV002953933	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002953933
7	128477554	VCV002953852	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002953852
7	128496592	VCV002953652	C	CCTTCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002953652
7	128470963	VCV002953603	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002953603
1	78392510	VCV002953278	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002953278
7	128478362	VCV002952887	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002952887
7	128480166	VCV002952852	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002952852
7	128494829	VCV002952757	C	CATCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002952757
7	128484058	VCV002952753	A	AGGTGGCTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002952753
7	128498501	VCV002952298	AAG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002952298
7	128496963	VCV002951806	GGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002951806
7	128483623	VCV002951186	G	GTCCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002951186
7	128488050	VCV002951068	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002951068
11	19209684	VCV002951005	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV002951005
7	128493037	VCV002950983	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002950983
7	128482352	VCV002950836	ACGT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002950836
7	128494039	VCV002950813	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002950813
7	128477212	VCV002950508	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002950508
7	128484236	VCV002950193	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002950193
15	35083354	VCV002950148	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=VCV002950148
7	128481612	VCV002949776	CTA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002949776
1	78392526	VCV002949465	A	AGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002949465
7	128492646	VCV002949084	T	TGATG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002949084
7	128486518	VCV002949075	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002949075
7	128470925	VCV002948927	CC	TT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002948927
7	128477212	VCV002948841	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002948841
7	128486112	VCV002948826	C	CACGTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002948826
7	128483899	VCV002948531	GCC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002948531
17	37821659	VCV002948047	A	AGC	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002948047
17	37821659	VCV002948047	A	AGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002948047
11	19207762	VCV002947685	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV002947685
1	78407769	VCV002947595	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002947595
7	128486388	VCV002947457	TCGCTGTGCCCAAGAGC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002947457
7	128493652	VCV002947448	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002947448
7	128478429	VCV002947265	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002947265
7	128498426	VCV002946991	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002946991
7	128488953	VCV002946214	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002946214
7	128484285	VCV002946078	GCTGTGGAGGGTGTC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002946078
7	128481016	VCV002945822	G	GGACA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002945822
7	128492885	VCV002945653	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002945653
7	128486458	VCV002945519	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002945519
7	128477741	VCV002945494	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002945494
7	128490498	VCV002945350	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002945350
7	128483606	VCV002945328	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002945328
7	128478326	VCV002945157	CGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002945157
7	128484211	VCV002944776	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002944776
7	128494463	VCV002944666	GCAGGTGAGGCCAGCTCTCAGGACATGACTGCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002944666
7	128470865	VCV002944589	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002944589
7	128494288	VCV002944299	GGCCGGCCGGGTCCTCACGGCGGGATGGGAGGGTGCTGCGGACCAGGCTTGATGCTGGCAGACTGGCCCCGAAGGCCAGGGCAGGTCTGAGCAGAGGAGGAGGTTTAACTGATGGGGGAGGGAAGGGCCAGGGCTAGGAGGAATCCCAGTGTTGCCCTGACATCCCCCAAACCCTGCAGGTGAGGCCAGCTCTCAGGACATGACTGCACAGGTGACCAGCCCATCGGGCAAGGTGGAAGCCGCAGAGATCGTCGAGGGCGAGGACAGCGCCTACAGCGTGCGCTTTGTGCCCCAGGAAATGGGGCCCCATACGGTCGCTGTCAAGTACCGTGGCCAGCACGTGCCCGGCAGCCCCTTTCAGTTCACTGTGGGGCCGCTGGGTGAAGGTGGTGCCCACAAGGTGCGGGCCGGAGGCACAGGGCTGGAGCGAGGTGTGGCCGGCGTGCCAGGTAAGGGGCAGGTGGCCAGGAGTGGGGATGAAGTCAGGGCAGCCAGTGTGAGGGGCGATGATGCTGAAGTCCACTACCTTGCCTGTCCCCAGCCGAGTTCAGCATCTGGACCCGGGAGGCTGGCGCTGGGGGCCTGTCCATTGCTGTGGAGGGTCCTA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002944299
7	128489038	VCV002943862	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002943862
7	128470813	VCV002943584	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002943584
7	128482306	VCV002943057	G	GAC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,LOC129999273;VARIANT_ID=VCV002943057
7	128478815	VCV002942828	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002942828
1	201334426	VCV002942386	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002942386
7	128493076	VCV002941970	CGCAATGCAGGTACCTCCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002941970
11	19209681	VCV002941886	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV002941886
7	128480215	VCV002941292	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002941292
7	128494831	VCV002941067	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002941067
1	78383725	VCV002940524	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126805765,NEXN;VARIANT_ID=VCV002940524
1	201334751	VCV002939571	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002939571
7	128478788	VCV002938892	CATACCGTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002938892
7	128496658	VCV002938838	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002938838
7	128478478	VCV002937732	C	CTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002937732
7	128486441	VCV002937408	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002937408
1	78383723	VCV002936967	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126805765,NEXN;VARIANT_ID=VCV002936967
7	128486961	VCV002935937	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002935937
7	128486196	VCV002935873	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002935873
7	128494737	VCV002934188	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002934188
7	128477282	VCV002933865	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002933865
11	19209778	VCV002932324	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV002932324
7	128481418	VCV002930258	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002930258
1	78394990	VCV002929334	TATTTGGTTAGGTAAATGAAGATGAGGAAAACCAAGAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002929334
7	128481223	VCV002924561	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002924561
7	128486162	VCV002922627	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002922627
7	128494484	VCV002922346	GACATGACTGC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002922346
7	128496909	VCV002922179	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002922179
7	128489234	VCV002921780	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002921780
7	128494573	VCV002921548	TGTGC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002921548
11	47372954	rs730880659T	TGCCA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880659T
11	47364697	VCV002911821	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002911821
6	74189566	VCV002901473	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002901473
11	47372167	VCV002866875	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002866875
11	47360143	VCV002864180	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002864180
6	74192238	VCV002863233	TAGAA	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002863233
11	47361205	VCV002861992	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002861992
11	47372917	VCV002861984	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002861984
6	74175947	VCV002858104	ATCCT	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002858104
14	23900677	VCV002853260	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002853260
11	47355515	VCV002852459	CTGAA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002852459
15	63335080	VCV002850868	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=VCV002850868
11	47356696	VCV002850865	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002850865
14	23897066	VCV002849030	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002849030
14	23898307	rs730880926C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880926C
19	55665538	VCV002847012	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002847012
11	47363607	VCV002845356	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002845356
14	23901935	VCV002840901	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002840901
6	74176330	VCV002839730	G	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002839730
11	47357561	VCV002838676	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002838676
11	47359107	VCV002837371	TC	AA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002837371
11	47353688	VCV002836894	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002836894
11	47355485	VCV002835256	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002835256
15	63336272	VCV002834088	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=VCV002834088
15	63351820	VCV002833135	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=VCV002833135
6	74183199	VCV002832033	AG	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002832033
11	47359127	VCV002829762	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002829762
11	47369973	VCV002829431	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002829431
11	47370077	VCV002826738	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002826738
11	47371325	VCV002825005	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002825005
11	47354495	VCV002823987	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002823987
14	23894117	VCV002823157	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV002823157
11	47353737	VCV002818733	CC	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002818733
14	23894989	VCV002818683	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002818683
14	23858209	VCV002817839	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 14;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH6;VARIANT_ID=VCV002817839
11	47371352	VCV002815832	C	CAGCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002815832
11	47372160	VCV002813081	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002813081
14	23898524	VCV002811677	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002811677
14	23897809	VCV002811256	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002811256
14	23894055	VCV002803488	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV002803488
19	55667664	VCV002798268	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002798268
11	47374173	VCV002798109	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002798109
11	47360892	VCV002797048	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002797048
14	23898503	VCV002794879	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002794879
14	23893328	VCV002793440	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002793440
14	23886123	VCV002780272	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=VCV002780272
11	47372129	VCV002780212	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002780212
11	None	VCV002775400	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002775400
11	47373029	VCV002773777	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002773777
11	47369014	VCV002773761	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002773761
11	47367848	VCV002773757	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002773757
11	47362757	VCV002773735	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002773735
11	47355292	VCV002773711	CCG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002773711
11	47353747	VCV002773698	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002773698
11	47371359	VCV002771180	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002771180
11	47361308	VCV002770644	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002770644
11	47354220	VCV002768329	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002768329
11	47367827	VCV002767904	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002767904
11	47369425	VCV002767742	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002767742
11	47370086	VCV002767317	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002767317
14	23893316	VCV002763277	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002763277
11	47359083	VCV002762843	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002762843
11	47369032	VCV002760797	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002760797
11	47354147	VCV002760232	CAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002760232
11	47353434	VCV002758819	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002758819
19	55668417	VCV002757968	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002757968
11	47372124	VCV002755478	T	TCAGCAGGGGCAGGGGCAGGGGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002755478
11	47372124	VCV002755478	T	TCAGCAGGGGCAGGGGCAGGGGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002755478
11	47359074	VCV002749151	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002749151
11	47361221	VCV002748128	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002748128
11	47353684	VCV002743278	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002743278
11	47371409	VCV002743183	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002743183
14	23901997	VCV002736096	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002736096
14	23899818	VCV002736091	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002736091
14	23895185	VCV002736084	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002736084
11	47370000	VCV002735602	GCAGT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002735602
11	47367858	VCV002735600	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002735600
11	47367757	VCV002735598	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002735598
11	47365170	VCV002735597	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002735597
11	47359132	VCV002735592	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002735592
11	47356651	rs786204352CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204352CA
11	47356651	rs786204352CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204352CA
11	47371394	VCV002720244	TTTGCCCTTGAACCACTTGACCACAGGCGGCTTCAGGAGGCTGGCGCCGGCCACGCGGGCTGAGAAGGTGATGCTGCCACCTGCAAAGGCAGG	AAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002720244
11	47363633	VCV002719504	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002719504
6	74171713	VCV002718305	C	CA	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002718305
11	47355147	VCV002707778	TCTCAATGCGCACCGTCACCTGGTAAGTGCCTGAATGCACGCGGCGAGCGGCCCGGATGAACAGGATGGTGTCTGTGGGGCTGTTGCGGATGCTCACCTCCTCGCCTGCCAGGGGCTGCCCCTCTTTGGTCCAGGTCACCTGAGGCCGGGGCTTGCCCTGAGGGGAGGAAAAGCTTAACCCTGAACCTGGATCACTCCAAGGGCCGGCCGCCACC	GGCCTGGTA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002707778
11	47354466	VCV002706649	ATGAGCTC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002706649
11	47372825	VCV002704454	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002704454
11	47354389	VCV002702912	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002702912
14	23882965	VCV002702266	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002702266
11	47354413	VCV002702173	TAA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002702173
11	47355527	VCV002700754	GCGCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002700754
14	23895185	VCV002699911	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002699911
11	47356672	VCV002699893	GA	TT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002699893
14	23885520	VCV002698681	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=VCV002698681
11	47371375	VCV002695123	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002695123
6	74191774	VCV002691508	CG	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002691508
11	47353689	VCV002687479	T	TCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002687479
19	55673650	VCV002683830	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=DNAAF3,DNAAF3-AS1,TNNI3;VARIANT_ID=VCV002683830
7	128488847	VCV002683829	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002683829
2	179569336	VCV002672152	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV002672152
14	23886756	VCV002671917	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=VCV002671917
14	23886756	VCV002671917	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=VCV002671917
14	23896848	VCV002644105	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002644105
11	47354395	VCV002627556	T	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002627556
7	128478055	VCV002585955	C	CAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002585955
7	128483629	VCV002585953	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002585953
11	47357486	VCV002584336	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002584336
11	47357486	VCV002584336	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002584336
11	47372856	VCV002582595	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002582595
2	179484799	VCV002582323	TA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV002582323
2	179413682	VCV002581068	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV002581068
11	47358941	VCV002580978	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002580978
11	47358941	VCV002580978	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002580978
7	128487870	VCV002579644	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002579644
14	23894908	VCV002577034	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002577034
14	23894908	VCV002577034	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002577034
11	47371563	VCV002577005	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002577005
11	47355278	VCV002577004	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002577004
11	47356690	VCV002577003	CGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002577003
11	47364164	VCV002577002	CTAGTGCACAGTGCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002577002
11	47364164	VCV002577002	CTAGTGCACAGTGCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002577002
2	179610674	VCV002577000	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=VCV002577000
20	33582206	VCV002576998	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=VCV002576998
14	23894976	VCV002576997	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002576997
14	23897099	VCV002576996	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002576996
14	23869949	VCV002576995	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 14;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH6;VARIANT_ID=VCV002576995
14	23886887	VCV002574110	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002574110
11	47364643	VCV002574108	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002574108
7	128477462	VCV002574075	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002574075
7	128488981	VCV002574074	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002574074
7	128486843	VCV002574073	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002574073
7	128485310	VCV002574072	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002574072
7	128485155	VCV002574071	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002574071
7	128480925	VCV002574070	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002574070
11	47364621	VCV002572994	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002572994
11	47363675	rs730880644C	CTGCGA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880644C
11	47356716	VCV002507019	A	ATGTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002507019
11	47358988	VCV002506163	G	GA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002506163
11	47371418	VCV002505579	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002505579
11	47364594	VCV002505346	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002505346
11	47369413	VCV002505335	GC	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002505335
1	201334420	VCV002500774	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002500774
2	179451375	VCV002500106	T	TTACTC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV002500106
11	47358960	VCV002448101	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002448101
7	128489633	VCV002446044	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002446044
11	47371588	VCV002444426	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444426
11	47372070	VCV002444406	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444406
1	201331512	VCV002444397	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002444397
11	47360138	VCV002444392	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444392
19	55665492	VCV002444295	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002444295
11	47373057	VCV002444293	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444293
7	128484862	VCV002444230	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002444230
11	47361199	VCV002444212	TA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444212
11	47365149	VCV002444081	AGGCC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444081
11	47353759	VCV002444036	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002444036
2	179472914	VCV002441726	CAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806425,TTN,TTN-AS1;VARIANT_ID=VCV002441726
7	128498202	VCV002441651	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002441651
7	128470736	VCV002441637	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002441637
6	74171662	VCV002431661	A	AGC	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002431661
6	74191743	VCV002425767	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002425767
6	74183068	VCV002425765	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002425765
6	74189435	VCV002425764	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002425764
6	74175912	VCV002425763	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002425763
6	74183068	VCV002425760	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002425760
7	128475360	VCV002424181	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002424181
7	128470692	VCV002424180	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002424180
7	128480199	VCV002424179	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002424179
7	128480619	VCV002424178	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002424178
11	47357408	VCV002422691	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002422691
11	47364109	VCV002422690	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002422690
11	47353958	VCV002422689	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002422689
11	47362467	VCV002422688	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002422688
11	47357408	VCV002422684	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002422684
1	201334742	VCV002202921	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002202921
6	74191953	VCV002196399	G	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002196399
11	47368976	VCV002185834	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002185834
14	23889203	VCV002177351	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002177351
6	74201961	VCV002157351	C	CT	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002157351
1	78392400	VCV002156496	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002156496
14	23886395	VCV002155573	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=VCV002155573
7	128484215	VCV002152041	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002152041
6	74192201	VCV002150945	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002150945
6	74191920	VCV002150102	G	GT	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002150102
12	111348980	VCV002148683	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=VCV002148683
11	47372863	VCV002137086	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137086
11	47364487	VCV002137082	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137082
11	47363541	VCV002137078	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137078
11	47358994	VCV002137074	GTTGAC	ATGA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137074
11	47356591	VCV002137070	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137070
11	47353722	VCV002137067	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137067
11	47353722	VCV002137067	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002137067
14	23899866	VCV002135797	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002135797
7	128481272	VCV002134738	AGG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002134738
7	128482753	VCV002133025	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002133025
11	47363556	VCV002133023	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002133023
1	78398997	VCV002132590	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002132590
14	23894524	VCV002132571	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV002132571
7	128489027	VCV002132527	CTCGTCACAGGTGGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002132527
11	47360145	VCV002132282	TCTTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002132282
7	128482744	VCV002131895	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002131895
6	74176316	VCV002129741	TGG	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002129741
7	128494506	VCV002127858	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002127858
11	47357563	VCV002125400	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002125400
11	47371406	VCV002124940	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002124940
7	128482319	VCV002124030	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002124030
7	128491602	VCV002124018	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002124018
11	47364624	VCV002123994	GGCTGCGTCGTCCGCCAATGAGC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002123994
1	78407735	VCV002123226	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002123226
11	47360048	VCV002121766	GCTTGGACCCCGGCCGGCCTCACCGATGAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002121766
6	74176126	VCV002119738	AT	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002119738
1	78392282	VCV002118680	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002118680
11	47356640	VCV002118635	C	CCAGGCCCTGCCATATTGTGTGCCCGCACTCGGAAAAGCAGCCGGGCCCCCGTGGGCAGGTCCTTCACCAGTATCGATGTGTGCTCTGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002118635
7	128488123	VCV002117644	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002117644
11	47364380	VCV002117457	CC	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002117457
11	47357557	VCV002116806	GGGGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002116806
7	128486109	VCV002116779	AACCACGTG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002116779
1	201333470	VCV002115456	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002115456
7	128489392	VCV002112130	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002112130
7	128492930	VCV002111182	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002111182
11	47370059	VCV002109962	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002109962
2	179437749	VCV002109910	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV002109910
7	128483009	VCV002107538	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002107538
7	128490856	VCV002107251	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002107251
11	47371607	VCV002107046	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002107046
1	78392423	VCV002103973	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV002103973
7	128492720	VCV002103216	ATC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002103216
11	47367361	VCV002102616	AGAGGGTTAACCGGGCTTCATTTCTTTTCAGAAGAGGGTAGAGAAAGAAAGTGTAGCCTGATTTTTCCTTGGTGAGGAGGGTTAACCTGAGCTCTGTCCTTTTCCTTGTGGCTGTCCTGGCCTAACTTTTGCTCTTCTCTTCTATCTCTGTGGTAAGGGGCTAACCTGGGCATTCTTGGCTTTTTCTACACAAGGAGGGGTTAACCTGGGCTCTTCTTTCCTGTGAGTCTCTGTGCTAAGCCGGACTCCGCTCTTTCCATGTATGTGGACGAGGTGGGGGGCTAACCTGTGCCCTCTCCTCTCCCCTGTGGGGAAGGGCTAACCTATGCCCTCTCCTCTCCTGTGTAGGGAAGGGCTAGCCTGTGCCCTCTCCTCTCCCCTCTGAGGAAGGGCTAACCTGTGCTCTTCTTCTCATCGCGCCTCATGCCCTTGAGCCTCTTTAGCATGCCGCGCAGGTCAGTGACGCCGTACTGGAAGGCGATGCGCTCGTACTCAGATGGGGGTGCCTGCCGTAGGATCTCCCACACGTCCTCCTCTGCTGGTGCCTCCAGCTTC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002102616
11	47354863	VCV002101639	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002101639
1	201334409	VCV002100789	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=VCV002100789
7	128478436	VCV002098290	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002098290
11	47372053	VCV002097401	CTTTGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002097401
11	47362796	VCV002095824	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002095824
7	128488106	VCV002094400	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002094400
11	47372151	VCV002092661	ATGGGCTCTGCCTTCTCTGGAGGGGATCAGATGGGAGTCGTGGTGCAGCCACTAACCAGAGACCCCTCCACCCTCTCTCTCCTGAGCATTGGACCCATGAGCCCGCTGTGGATGAGGAAAGTCTGCCATGGCTGTCCTCCCGCTGCCTGGGCCCCTCAGAGGCAGCTCATGCTGAGCTGGAGAGCCAGCC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002092661
11	47371564	VCV002091607	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002091607
11	47367789	VCV002090163	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002090163
17	37822005	VCV002090126	GACCT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002090126
17	37822005	VCV002090126	GACCT	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002090126
7	128480643	VCV002090044	GGTGTGTTC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002090044
7	128493522	VCV002088457	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002088457
19	55668427	VCV002088003	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002088003
19	55665423	VCV002088002	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002088002
7	128477239	VCV002088000	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002088000
7	128491515	VCV002086291	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002086291
11	47362764	VCV002080547	GTGTGACGTCGTCAA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002080547
7	128494694	VCV002078323	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002078323
7	128491627	VCV002076455	CGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002076455
11	47357435	VCV002075185	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002075185
11	47357435	VCV002075185	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002075185
11	47360097	VCV002069047	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002069047
17	37821654	VCV002065429	CTG	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002065429
17	37821654	VCV002065429	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002065429
11	47356762	VCV002060811	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002060811
11	47356762	VCV002060811	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002060811
11	47357518	VCV002055757	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002055757
11	47372063	VCV002054854	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002054854
7	128486798	VCV002052802	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002052802
7	128478409	VCV002050858	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002050858
7	128484101	VCV002045753	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002045753
7	128498509	VCV002040119	T	TC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002040119
7	128497170	VCV002039536	A	AGGTGTGTCATCAGAGTTCATCGTGAACACCCTGAATGCCGGCTCGGGGGCCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002039536
6	74202077	VCV002038148	T	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002038148
7	128483952	VCV002036851	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002036851
7	128485197	VCV002036561	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002036561
7	128478756	VCV002036320	GCTGCACATACAGAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002036320
14	23895207	VCV002033293	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002033293
11	47364061	VCV002032613	GGCTAGGTGGGGTGGGGGCTGAGGGGTCCAAGCCCTAAAGCCTCATGTGCCCCCCCAGCCAGGCTCACCCTGCACAATGAGCTCAGCCAGCGCCTGGCCCCCGCTAGTGCACAGTGCATAGTGCCCCGCGTCCTCCAGCATGGCCTCGTTGATGATCAGGTGGTGTCTCTGCCCGTCCTTCTTGAACCGGTATTTGAAGGTCTCCTCCCGGGTCAGCTCCACCCCGTCCTTCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002032613
7	128475604	VCV002029646	GCCCTGGTGGACAACTGCGCC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002029646
7	128481259	VCV002029632	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002029632
14	23897742	VCV002028449	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV002028449
11	47356722	VCV002026549	GCT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002026549
7	128494491	VCV002025611	C	CTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002025611
11	47363665	VCV002025465	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002025465
7	128486199	VCV002025130	TAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002025130
1	78383861	VCV002023692	AAAGG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126805765,NEXN;VARIANT_ID=VCV002023692
17	37821724	VCV002023376	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002023376
17	37821724	VCV002023376	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV002023376
11	47354134	VCV002023196	C	CAGCACAGCAG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002023196
7	128494550	VCV002022526	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002022526
11	47371449	VCV002021725	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002021725
11	47371618	VCV002020668	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002020668
7	128494628	VCV002019903	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002019903
7	128483953	VCV002019122	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002019122
7	128497392	VCV002017760	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV002017760
11	47354388	VCV002017183	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002017183
6	74183272	VCV002016252	AC	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV002016252
15	35084644	VCV002015662	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=VCV002015662
7	128484302	VCV002012084	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002012084
7	128487821	VCV002010046	G	GGGGGCTGGTGTCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002010046
19	55665575	VCV002008537	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV002008537
11	47354452	VCV002006860	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002006860
11	47365149	VCV002006010	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002006010
11	47360183	VCV002005925	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002005925
11	47371564	VCV002004272	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002004272
11	47362743	VCV002003751	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV002003751
7	128480639	VCV002002800	GGATGGTGTGTTCGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002002800
7	128486448	VCV002000070	TCC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV002000070
7	128492690	VCV001999789	C	CGGACGTGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV001999789
14	23894209	VCV001997857	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV001997857
11	47371361	VCV001997854	GTGCTGGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001997854
7	128494101	VCV001995398	CCGCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV001995398
11	47364473	VCV001994281	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001994281
19	55665438	VCV001994254	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV001994254
1	78399078	VCV001993576	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=VCV001993576
11	47364458	VCV001993574	C	CAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001993574
7	128485251	VCV001993513	G	GCAGCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001993513
11	47360957	VCV001990793	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001990793
19	55668678	VCV001990531	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV001990531
2	179403850	VCV001988966	CTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=VCV001988966
6	74189689	VCV001986427	GC	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV001986427
6	74190402	VCV001979871	CG	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV001979871
14	23883235	VCV001978588	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV001978588
11	47353657	VCV001959572	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001959572
7	128487781	VCV001953038	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001953038
7	128486863	VCV001952547	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001952547
14	23894051	VCV001929447	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=VCV001929447
7	128486940	VCV001878987	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001878987
11	47354526	VCV001878689	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001878689
14	23901014	rs730880845T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880845T
14	23901014	rs730880845T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880845T
12	111348894	VCV001804172	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=VCV001804172
11	47355170	VCV001803540	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001803540
11	47354383	VCV001803137	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001803137
11	47362709	VCV001801830	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001801830
22	21344759	VCV001801829	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LZTR1;VARIANT_ID=VCV001801829
7	128484057	VCV001797807	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001797807
11	47357522	VCV001794150	G	GACGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001794150
2	179472387	VCV001793398	AAC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806425,TTN,TTN-AS1;VARIANT_ID=VCV001793398
11	47359042	VCV001792248	CCG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001792248
11	47360067	VCV001789115	TCACCGATGACCTTGACTGTGA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001789115
11	47361318	VCV001783224	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001783224
14	23896887	VCV001780256	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV001780256
11	47363554	VCV001779902	GA	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001779902
11	47363554	VCV001779902	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001779902
11	47364391	rs730880541A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880541A
11	47364572	rs786204338A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204338A
11	47364615	VCV001769560	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001769560
7	128477528	VCV001760635	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001760635
7	128495351	VCV001757829	ACT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV001757829
11	47364659	VCV001754401	TCAGGGTACGCTTGGCACCGATGGACTCAAAGATGTACCTGGGTGGGGGCCGCAGGGAAGTGGCAGGAAAGCTGCGG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001754401
7	128491618	VCV001749582	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV001749582
11	19206594	rs1850502742G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1850502742G
11	19207800	VCV001734830	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=VCV001734830
11	47354096	VCV001733001	CCAGCGCCTAAAGTTCCCTACCTTGGGGCTACCCCGGACAGCACAGCAGAGCATAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001733001
7	128471027	VCV001730885	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001730885
11	47354832	VCV001729315	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001729315
11	47354867	VCV001728884	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001728884
15	63354430	VCV001727219	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=VCV001727219
11	47367929	VCV001723021	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001723021
15	63353116	VCV001721605	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=VCV001721605
7	128486196	VCV001710103	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001710103
7	128497190	VCV001710099	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=VCV001710099
7	128494646	VCV001710097	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=VCV001710097
11	47354841	VCV001709166	CCAGGCGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001709166
6	118880145	VCV001709041	CCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 18;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CEP85L,PLN;VARIANT_ID=VCV001709041
17	37822215	VCV001708038	GGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=VCV001708038
7	128484971	VCV001705399	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001705399
11	47359094	VCV001705387	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001705387
11	47364157	VCV001705378	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001705378
11	47353632	VCV001705335	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001705335
11	47354841	rs866966651T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs866966651T
1	201334431	rs2102262330T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs2102262330T
2	224824304	rs761343107A	G	A	.	PASS	PHENOTYPE=INFANTILE HYPERTROPHIC CARDIOMYOPATHY DUE TO MRPL44 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MRPL44;VARIANT_ID=rs761343107A
2	179517660	rs1185989004G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs1185989004G
14	23899101	rs2138677574T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138677574T
11	47369457	rs2142865708G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142865708G
11	47364225	rs2142861049G	GTC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142861049G
14	23898221	rs1555338319A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338319A
11	47355129	rs760491068T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs760491068T
11	47353665	rs2142849245A	AGTTG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142849245A
11	47363687	rs2142860329A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142860329A
1	78401507	rs1650708891A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs1650708891A
2	179433674	rs542074139A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs542074139A
1	78401667	rs777418673T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs777418673T
11	47364430	rs1595846365A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595846365A
14	23884594	rs727505294C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs727505294C
3	46902449	rs2106910461T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 8;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs2106910461T
14	23897818	rs2138674215C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138674215C
11	47364805	rs2142861940T	ACTTACTTGCTGTAGAACAGAAGGGGCCGTTGAAGTGTTCCCGACGGGAGGAAGTGAGCCCGAGACAAAAGGAGAGAGAGAGAGGGACCGGCAGGAGCAAAAGGATGGGAAATTAGGCCCAGAGAGATGGGGCTGAGAGCCACACCGAGTCAGAGATACGCATGTGGAGAGGGGCAGGAGGCAAGGCTATGGGGGTCCCCACCTCCACCCGAGCCCCCCTCCCCACCCCAGGCTGCACCTGCCGCTCATCTGGATCTCCTGGCCATTCTTGAGCCATTTGACCTCAGCGTCATGGTCAGCCAGTTCCACGGTCAGCCGGATCTTGTGGC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142861940T
14	23883215	rs1892079951A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892079951A
11	47372052	rs1223603416T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1223603416T
2	179430479	rs2154165062A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2154165062A
14	23897769	VCV001507354	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV001507354
14	23895189	rs121913638A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913638A
7	128483632	rs2128936028T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936028T
11	47365177	rs2142862326C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142862326C
14	23901855	rs1555338758G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338758G
14	23883016	rs2138635168A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138635168A
14	23901922	rs397516209G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209G
14	23901922	rs397516209G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209G
14	23899061	rs2138677416T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138677416T
7	128489260	rs1585164316C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585164316C
11	47368176	rs1595847941G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595847941G
2	179455995	rs2154184873C	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2154184873C
11	47355106	rs2142851321A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142851321A
14	23884349	rs2138638382G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138638382G
11	47371664	rs185449721T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs185449721T
11	47371664	rs185449721T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs185449721T
7	128491683	rs2128938502A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938502A
7	128497391	rs1563005607C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563005607C
14	23896876	rs2138672051C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138672051C
14	23885373	rs2138642157G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs2138642157G
7	128477603	rs1808146842T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808146842T
7	128490855	rs2128938204C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938204C
7	128486218	rs1808557594T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808557594T
14	23895001	rs1060501448T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1060501448T
7	128477603	rs1808146842A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808146842A
7	128491284	rs111477195G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs111477195G
7	128494721	rs2128939561A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939561A
7	128487998	rs1404524040A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1404524040A
7	128496706	rs112941619C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs112941619C
15	63349235	rs730881131A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs730881131A
15	63349235	rs730881131A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs730881131A
7	128478858	rs2128934545T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934545T
11	19209798	rs2133511280T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs2133511280T
15	35085745	rs2140432240G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs2140432240G
14	23894048	rs36211715G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs36211715G
11	47357563	rs977277400T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs977277400T
1	78399163	rs2102147202A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs2102147202A
11	47355486	rs2142851880A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142851880A
6	74171578	VCV001460431	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV001460431
11	47369442	rs373730381A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373730381A
11	47368992	rs2142865199C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142865199C
11	47353690	rs2142849315G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142849315G
7	128483574	rs2128936013TC	T	TC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936013TC
11	47360157	rs730880650GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880650GC
17	37821644	rs1555606959C	CG	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1555606959C
17	37821644	rs1555606959C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1555606959C
7	128475618	rs2128933700C	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128933700C
7	128494177	rs2128939316T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939316T
11	47354746	rs2142850736A	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850736A
7	128488715	rs2128937556G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937556G
7	128485227	rs2128936518C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936518C
7	128494034	rs2128939246A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs2128939246A
7	128477221	rs1455396332A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1455396332A
11	47356640	rs2142852868CCCAGGCCCTGCCATATTGTGTGCCCGCACTCGGAAAAGCAGCCGGGCCCCCGTGGGCAGGTCCTTCACCAGTATCGATGTGTGCTCTGTCAGCCCCTG	C	CCCAGGCCCTGCCATATTGTGTGCCCGCACTCGGAAAAGCAGCCGGGCCCCCGTGGGCAGGTCCTTCACCAGTATCGATGTGTGCTCTGTCAGCCCCTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142852868CCCAGGCCCTGCCATATTGTGTGCCCGCACTCGGAAAAGCAGCCGGGCCCCCGTGGGCAGGTCCTTCACCAGTATCGATGTGTGCTCTGTCAGCCCCTG
7	128477267	rs2128934070C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934070C
6	74171578	VCV001456323	None	None	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=VCV001456323
11	47359319	rs1057518030TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1057518030TG
11	47372966	rs2142869736T	TTCAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142869736T
11	47354859	rs2142851045GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142851045GC
6	74189684	rs2150035785G	GTT	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150035785G
11	47354746	rs2142850741A	ATGGTCTTCTTGTCGGCTTTC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850741A
7	128487731	VCV001455469	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001455469
11	47359031	rs1219930764TC	T	TC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1219930764TC
7	128478342	rs2128934390T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934390T
6	74190512	rs1250411982A	AG	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1250411982A
7	128485213	rs2128936511G	GGGCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936511G
11	47358953	rs2142855105AAGGGCTGGGAGGC	A	AAGGGCTGGGAGGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142855105AAGGGCTGGGAGGC
11	47358953	rs2142855105AAGGGCTGGGAGGC	A	AAGGGCTGGGAGGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142855105AAGGGCTGGGAGGC
11	47359050	rs2142855351A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142855351A
7	128480714	rs376975967A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs376975967A
7	128483560	rs2128936006G	GTTGTGCGGGAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936006G
7	128475582	rs2128933685A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128933685A
7	128481547	rs2128935347A	ATC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935347A
6	74176219	rs2150027394T	TCTTGAATACACCACTG	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150027394T
11	47372056	rs2142868665A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142868665A
11	47353664	rs730880604T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880604T
7	128475512	rs2128933653AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128933653AG
7	128498449	rs1809161384G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1809161384G
7	128488104	rs2128937368A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937368A
7	128478704	rs2128934500C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934500C
11	47365071	rs2142862199T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142862199T
11	47371305	VCV001452187	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001452187
11	47355169	rs573821685C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs573821685C
7	128498261	rs2128940614A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128940614A
7	128480941	rs2128935124A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935124A
7	128480167	rs2128934883CCA	C	CCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934883CCA
19	55667549	VCV001449490	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=VCV001449490
11	47371438	rs2142867804C	CGCCG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142867804C
7	128477276	rs2128934074G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934074G
11	47353733	rs2142849399A	ACT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142849399A
6	74191907	rs764848745T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs764848745T
11	47356685	rs2142852944G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142852944G
7	128483849	rs2128936072GGGCAACAT	G	GGGCAACAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936072GGGCAACAT
7	128477544	rs2128934191T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934191T
7	128492947	rs2128938894G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938894G
1	201334749	rs1659515084T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs1659515084T
7	128496828	rs948675422T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs948675422T
7	128496626	rs2128940130GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128940130GC
6	74207550	rs2150044996G	T	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150044996G
7	128483349	rs771092335T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs771092335T
7	128496920	rs2128940259T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128940259T
3	8787427	rs2124988641A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CAV3,OXTR;VARIANT_ID=rs2124988641A
7	128483883	rs2128936089G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936089G
7	128481300	rs2128935258G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935258G
11	47372904	rs1410935154A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1410935154A
7	128492668	rs2128938768T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938768T
7	128484737	rs2128936346AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936346AG
7	128478382	rs2128934407TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934407TG
6	74207491	rs2150044955T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150044955T
11	19213910	rs2133516329C	CTCCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs2133516329C
7	128494845	rs2128939606A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939606A
19	55665398	rs2085710902A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs2085710902A
1	78383424	rs999958582A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs999958582A
14	23887540	rs1316692489T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1316692489T
11	47374198	rs1461764618A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1461764618A
14	23896018	rs730880883G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880883G
11	47362578	rs2142859071A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142859071A
6	74189681	rs148667065T	A	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs148667065T
1	201334389	rs727504245T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504245T
11	47357552	VCV001396529	GCTGGGGGGAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001396529
7	128491353	rs2128938382G	GAGCCATGGCATGGTCAACAAGCC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938382G
7	128494264	rs2128939369T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939369T
11	47360950	rs2142857362A	ATT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142857362A
14	23886202	rs2138644623C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs2138644623C
11	47361316	rs936188645T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs936188645T
19	55668013	rs2147285332G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs2147285332G
11	47355173	rs2142851443G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142851443G
7	128482659	rs2128935670C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935670C
7	128484146	rs2128936173C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936173C
11	47368990	rs2142865197G	GTGAGC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142865197G
6	74202065	rs2150042308GA	G	GA	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150042308GA
17	37822024	rs1435437660T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1435437660T
17	37822024	rs1435437660T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1435437660T
1	78399129	rs2102146999CAAGAATTTGAACAACTGGCCGGGCCCGGTGGCTCACGCCTGTAATCCCAGCACATTGGGAGGCCGAGACTGGAGGATCACGAGTTCAGGAGATCGATACCATACANNNNNNNNNNAAAAAAAAAAAAAAAAAAAA	C	CAAGAATTTGAACAACTGGCCGGGCCCGGTGGCTCACGCCTGTAATCCCAGCACATTGGGAGGCCGAGACTGGAGGATCACGAGTTCAGGAGATCGATACCATACANNNNNNNNNNAAAAAAAAAAAAAAAAAAAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs2102146999CAAGAATTTGAACAACTGGCCGGGCCCGGTGGCTCACGCCTGTAATCCCAGCACATTGGGAGGCCGAGACTGGAGGATCACGAGTTCAGGAGATCGATACCATACANNNNNNNNNNAAAAAAAAAAAAAAAAAAAA
11	47364463	rs2142861454G	GGCGCGTGATGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142861454G
11	19207847	rs2133508524G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs2133508524G
14	23894591	rs2138667243T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2138667243T
7	128494202	rs2128939337C	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939337C
11	47364645	rs746770543T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs746770543T
7	128475555	rs2128933676G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128933676G
11	47354766	rs2142850807C	CTGCACTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850807C
14	23895207	rs2138668839C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138668839C
11	47362763	rs2142859359G	GGT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142859359G
14	23896059	rs760736597G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs760736597G
7	128477282	rs2128934076C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934076C
11	47367883	rs2142864321T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142864321T
7	128491523	rs2128938435C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938435C
7	128480125	rs2128934867A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934867A
11	47356737	rs367729718A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs367729718A
7	128470793	rs2128932126A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128932126A
11	47354843	rs2142850980AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850980AG
14	23884439	rs2138638712A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138638712A
11	47353422	VCV001359238	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001359238
7	128486960	rs2128937065A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937065A
7	128489038	rs2128937680G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937680G
7	128483967	rs2128936119A	AGTAAGT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936119A
11	47355562	rs1409755826T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1409755826T
7	128488671	rs1427917546A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1427917546A
14	23895249	rs2138668970A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138668970A
11	47364172	rs2142860924C	CAGTGCAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142860924C
12	111353546	rs2136774043C	CG	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs2136774043C
14	23894579	rs1427104281T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1427104281T
5	130766131	VCV001335875	None	None	.	PASS	PHENOTYPE=IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FNIP1,RAPGEF6;VARIANT_ID=VCV001335875
5	130987494	rs2149504053T	C	T	.	PASS	PHENOTYPE=IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FNIP1;VARIANT_ID=rs2149504053T
5	131042150	rs2149534097A	G	A	.	PASS	PHENOTYPE=IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FNIP1;VARIANT_ID=rs2149534097A
5	130987582	rs2149504123C	CA	C	.	PASS	PHENOTYPE=IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FNIP1;VARIANT_ID=rs2149504123C
5	131014781	rs2149518317G	GT	G	.	PASS	PHENOTYPE=IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FNIP1;VARIANT_ID=rs2149518317G
5	130982852	rs2149501551T	C	T	.	PASS	PHENOTYPE=IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FNIP1;VARIANT_ID=rs2149501551T
11	47362553	rs2142859053A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142859053A
11	47362553	rs2142859053A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142859053A
2	179590657	rs2154304590A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs2154304590A
14	23897756	rs1333791654G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1333791654G
14	23896838	rs1892745662G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892745662G
11	47372995	rs2142869802G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142869802G
14	23897861	rs397516107A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516107A
11	47364144	rs2142860830A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142860830A
11	47364144	rs2142860830A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142860830A
11	47370094	rs1219818351C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1219818351C
14	23894147	rs1060501439C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060501439C
11	47360232	rs2142856729G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142856729G
14	23897739	rs2138673993T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138673993T
11	47354761	rs2142850797GCC	G	GCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850797GCC
11	47354761	rs2142850797GCC	G	GCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850797GCC
14	23893327	rs397516165A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516165A
14	23893358	rs2138664054T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138664054T
14	23896496	rs2138671179C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138671179C
11	47356730	rs2142853009A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142853009A
11	47364128	rs1252584025G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1252584025G
6	74176113	rs769532203C	CTA	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs769532203C
2	179399700	rs2154136345C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2154136345C
11	19213945	rs1336937886GAAGAAATCTGC	G	GAAGAAATCTGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1336937886GAAGAAATCTGC
11	47354550	rs2142850484C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850484C
7	128477552	rs2128934193C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934193C
14	23889413	rs753801146G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs753801146G
14	23901922	rs397516209A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516209A
7	128494112	rs762680314C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs762680314C
11	47360874	rs1060499604T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060499604T
2	179427534	rs2154160971TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2154160971TA
12	111350926	rs1064796377A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs1064796377A
1	201332507	rs1558225569G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs1558225569G
11	47364128	rs1252584025T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1252584025T
7	128483876	rs769390195A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs769390195A
2	224824538	rs143697995C	T	C	.	PASS	PHENOTYPE=INFANTILE HYPERTROPHIC CARDIOMYOPATHY DUE TO MRPL44 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MRPL44;VARIANT_ID=rs143697995C
2	224824552	rs2106116608TC	ACTG	TC	.	PASS	PHENOTYPE=INFANTILE HYPERTROPHIC CARDIOMYOPATHY DUE TO MRPL44 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MRPL44;VARIANT_ID=rs2106116608TC
14	23894191	rs2138666198T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2138666198T
11	19206593	rs775194825A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs775194825A
14	23901935	rs2138684666A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138684666A
11	47362580	rs2142859074A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142859074A
11	47354127	rs1057517769A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1057517769A
11	47368177	rs767239679G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs767239679G
7	128484825	rs2128936386C	CTGCGAGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936386C
7	128481026	rs113483303C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs113483303C
14	23900636	rs2138681177G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs2138681177G
11	47362746	rs2142859289A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142859289A
11	47362755	rs730880555A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880555A
7	128483939	rs2128936107C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936107C
6	74192204	rs372842922T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs372842922T
11	47372053	rs1555123597C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123597C
7	128488099	rs2128937364A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937364A
11	47357416	VCV001075727	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001075727
11	None	VCV001075725	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001075725
14	23885376	rs2138642164G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs2138642164G
7	128486940	rs756985550CG	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs756985550CG
11	47354498	rs1565622952C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565622952C
7	128481303	rs1808320936A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808320936A
11	47367798	rs2142864164C	CTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142864164C
11	47364484	rs2142861512G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142861512G
7	128470837	rs2128932142AT	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128932142AT
7	128494601	rs2128939508GTCGC	G	GTCGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939508GTCGC
7	128483006	rs1367760687T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1367760687T
7	128475588	rs2128933688C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128933688C
11	47360215	rs730880696A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880696A
11	47360215	rs730880696A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880696A
7	128491302	rs2128938355C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938355C
7	128497358	rs2128940399TCGTGGGCAGCCCCTTCAAGG	T	TCGTGGGCAGCCCCTTCAAGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128940399TCGTGGGCAGCCCCTTCAAGG
11	47356759	rs2142853045G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142853045G
11	47372140	rs2142868794C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142868794C
6	74183284	rs755954353C	CAA	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs755954353C
7	128470846	rs2128932148GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128932148GC
7	128489251	rs1282619643T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1282619643T
6	74183219	rs2150031480T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150031480T
11	47354431	rs2142850286A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142850286A
7	128491410	rs2128938391A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938391A
7	128470872	rs2128932161T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128932161T
11	47370022	rs2142866256G	GACACCTC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142866256G
7	128493553	rs2128939085G	GCCCAAGCAAGGTGGACATCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939085G
7	128484198	rs2128936189T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936189T
7	128482957	rs1389742580A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1389742580A
7	128470951	rs2128932217A	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128932217A
7	128469483	VCV001071864	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001071864
7	128470682	VCV001071863	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001071863
7	128491311	rs2128938360T	TGCCATCAACA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938360T
11	47371661	rs771005018A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs771005018A
7	128491572	rs2128938455AT	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938455AT
7	128480719	rs2128935054T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935054T
14	23900793	rs730880850A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880850A
11	47371413	rs2142867765A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142867765A
11	47361256	rs2095886347GCC	G	GCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095886347GCC
7	128488861	rs2128937622G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937622G
7	128494541	rs1156444972T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1156444972T
7	128490978	rs1808781579A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808781579A
7	128488752	rs2128937575A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937575A
11	47371464	rs2142867855AT	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142867855AT
7	128496580	rs2128940107G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128940107G
6	74202010	rs2150042284C	CT	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs2150042284C
11	47364640	rs2142861729A	AATGAGCACTGGCTG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142861729A
11	47364418	rs1415753419A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1415753419A
11	47364207	rs730880545A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880545A
11	47363602	rs2095889156T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095889156T
7	128483335	rs2128935921G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935921G
11	47360865	VCV001069833	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001069833
11	None	VCV001069832	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001069832
11	47353745	rs2142849434CTGAA	C	CTGAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142849434CTGAA
11	47364119	VCV001069672	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001069672
7	128494576	rs2128939496GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939496GC
7	128490524	rs2128938104AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938104AG
7	128481324	rs757352623G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs757352623G
7	128485218	rs2128936516T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128936516T
7	128481397	rs2128935287C	CCTGA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128935287C
7	128478477	rs2128934432A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128934432A
7	128487894	rs2128937285T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs2128937285T
7	128494691	rs2128939548C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128939548C
11	47372788	rs2142869314A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142869314A
2	179408031	rs2154143423T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806421,TTN,TTN-AS1;VARIANT_ID=rs2154143423T
11	47354885	rs2095879167G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095879167G
7	128491684	rs2128938503G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128938503G
15	63354782	rs2140974070G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs2140974070G
7	128497171	rs2128940335A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs2128940335A
7	128475370	VCV001067687	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV001067687
7	128489633	rs1465588989T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1465588989T
11	None	VCV001067413	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001067413
11	47362544	VCV001067412	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV001067412
11	47364128	rs1252584025A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1252584025A
2	179454111	rs2154183737C	CAGTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2154183737C
2	179441549	rs1247353236CCTTTT	C	CCTTTT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1247353236CCTTTT
2	179464578	rs1385817640T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1385817640T
11	47364376	rs2142861325C	CTCACCATTTGACT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2142861325C
3	52486156	rs199523612G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 13;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs199523612G
7	128478119	rs762493013A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs762493013A
17	37822029	rs369447207A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs369447207A
17	37822029	rs369447207A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs369447207A
7	128488846	rs1808678197A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808678197A
14	23884421	rs397516246A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516246A
14	23900812	rs202141819C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs202141819C
17	37821727	rs794729178A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs794729178A
17	37821727	rs794729178A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs794729178A
14	23896484	rs1892730026T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892730026T
19	55666108	rs111406690T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs111406690T
14	23886457	rs1176998293T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs1176998293T
19	55668677	rs397516340T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516340T
14	23882985	rs755706526A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs755706526A
14	23897715	rs769484001C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs769484001C
11	47355472	rs2095879885T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095879885T
11	47360891	rs2095885868T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095885868T
3	52486194	rs1706339531T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs1706339531T
14	23901856	rs730880920G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880920G
7	128496973	rs1809086992A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1809086992A
1	78407735	rs1425668712A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs1425668712A
19	55668006	rs772607683A	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs772607683A
1	78401557	rs747902604T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs747902604T
11	19213923	rs766395852A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs766395852A
11	19213940	rs776444956T	TGGTAGAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs776444956T
14	23886765	rs730880800C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs730880800C
11	19207800	rs1850523074C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1850523074C
15	63353113	rs1555409132A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1555409132A
6	74176055	rs1297994959T	TA	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1297994959T
2	179481455	rs779498825T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs779498825T
2	179446242	rs2047743679C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2047743679C
11	47354123	rs2095878223G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095878223G
5	68419233	rs1746589361T	TAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=SLC30A5;VARIANT_ID=rs1746589361T
5	68419233	rs1746589361T	TAC	T	.	PASS	PHENOTYPE=CONCENTRIC HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=SLC30A5;VARIANT_ID=rs1746589361T
2	179514069	rs758597536C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs758597536C
10	32324866	rs1841455410C	CTTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=KIF5B;VARIANT_ID=rs1841455410C
11	47353670	rs2095877685G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095877685G
11	47353670	rs2095877685G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095877685G
1	26387675	rs540072010A	ACT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TRIM63;VARIANT_ID=rs540072010A
14	23894000	rs1892625481T	TCATTCTTCTCCTGCAGCAGGGACACCATCTTCTCCTCCAGCTCCTTGCGGCGAGCCTCGGACTTCTCTAGCGCCTCTTTGAGGCGTGTGAACTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1892625481T
19	19637003	rs2061098856C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC125371495,NDUFA13;VARIANT_ID=rs2061098856C
19	19638108	rs2061105702C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NDUFA13;VARIANT_ID=rs2061105702C
1	201333484	rs754037135G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs754037135G
2	179455443	rs2050024892A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2050024892A
1	26387768	rs377334933C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TRIM63;VARIANT_ID=rs377334933C
11	47357427	rs2095881732C	CAGCCCTCTGGGCAGTACTCCACGCTGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095881732C
15	63335142	rs2031445986A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs2031445986A
19	55665509	rs2085712265A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs2085712265A
11	47365083	rs1233894123A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1233894123A
11	47365083	rs1233894123A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1233894123A
11	47364453	rs2095890455TCC	T	TCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095890455TCC
11	47364453	rs2095890455TCC	T	TCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095890455TCC
11	47364453	rs2095890455TCC	T	TCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095890455TCC
7	128491523	rs1808809268G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808809268G
5	68411798	rs1746359403G	GTTATC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=SLC30A5;VARIANT_ID=rs1746359403G
5	68411798	rs1746359403G	GTTATC	G	.	PASS	PHENOTYPE=CONCENTRIC HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=SLC30A5;VARIANT_ID=rs1746359403G
11	19206573	rs759269008C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs759269008C
7	128492808	rs1808874360C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808874360C
7	128492808	rs1808874360C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808874360C
3	8787396	rs1708139265A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CAV3,OXTR;VARIANT_ID=rs1708139265A
2	179396616	rs1689265228A	GAAAAGATATCAAATCTTGCAGACCTCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1689265228A
11	47371424	rs2095898569C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095898569C
7	128483335	rs1808416556T	GC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808416556T
7	128497367	rs1809109008A	GC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1809109008A
7	128483908	rs1401551498T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1401551498T
11	47362557	rs2095887873G	GCC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095887873G
7	128481583	rs1808334682C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808334682C
11	47365137	rs2095891398T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095891398T
11	47365137	rs2095891398T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095891398T
11	47370065	rs2095896870C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095896870C
7	128488903	rs1808681247A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808681247A
15	63353964	rs2035667597G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs2035667597G
14	23898196	rs1892810348G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892810348G
7	128485188	rs1808505973CTA	C	CTA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808505973CTA
14	23882988	rs1892066954T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892066954T
14	23882988	rs1892066954T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892066954T
11	47367849	rs367947846T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs367947846T
7	128493656	rs1808918080T	TGCTGACAA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808918080T
11	47357408	rs2095881691T	TTGGGGGCGGGGACACTCACAGCCCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095881691T
11	47364572	rs786204338G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204338G
7	128482965	rs1808400430C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808400430C
7	128478119	rs762493013T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs762493013T
11	47354183	rs2095878299C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095878299C
7	128493768	rs1808924231T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808924231T
14	23894026	rs1060505018T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060505018T
11	47353683	rs2095877711C	CAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095877711C
14	23896849	rs1393494996A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1393494996A
2	179438245	rs1708996209A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1708996209A
11	47354172	rs761545914T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs761545914T
2	179437914	rs879087983C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs879087983C
2	179393000	rs112188483G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs112188483G
11	47364296	rs397515903A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515903A
14	23893324	rs730880757T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880757T
7	128482393	rs1374893890T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1374893890T
7	128490474	rs1808758208T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808758208T
7	128496940	rs1809085817AG	CA	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1809085817AG
7	128497392	rs1809110247C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs1809110247C
7	128492784	rs1808872966G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808872966G
11	47364137	rs2095889815ATGAGG	A	ATGAGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095889815ATGAGG
11	47358973	rs2095883336G	GGGCCTGGACAT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095883336G
11	47364482	rs2095890510G	GGGCTCT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095890510G
2	179463948	rs745376275A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs745376275A
11	47372137	rs2095899755GGGCAGGGGCCAGC	G	GGGCAGGGGCCAGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095899755GGGCAGGGGCCAGC
14	23896453	rs606231328G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs606231328G
2	179434122	rs1707280155T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1707280155T
14	23893331	rs730880756G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880756G
11	47356591	rs2095880858T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095880858T
6	74191892	rs1459252796T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1459252796T
7	128484078	rs769865678T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs769865678T
7	128497180	rs1809097778T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1809097778T
7	128482887	rs776269505T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs776269505T
11	47355471	rs2095879886A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095879886A
19	55668425	rs1251941984TGC	T	TGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs1251941984TGC
7	128477731	rs1808153476C	CTTCACCGTGCAGACGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808153476C
7	128486042	rs1808546796A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808546796A
6	74171727	rs1770832882G	GGCAGCCACCGCCGCCGCTCGGT	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1770832882G
15	85400612	rs1963877824G	GGGGCCGTGTAGCACCCCGACTTCTCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs1963877824G
1	201333484	rs754037135T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs754037135T
14	23886764	rs780625785T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs780625785T
11	47369200	rs1194615408G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1194615408G
11	47369200	rs1194615408G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1194615408G
15	63353934	rs1131003T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1131003T
11	47357564	rs1419155559C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1419155559C
11	47357564	rs1419155559C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1419155559C
11	47372819	rs2095900581A	ACCTTGGAGGAG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095900581A
11	47360106	rs1163861044T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1163861044T
11	47360106	rs1163861044T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1163861044T
11	47353677	rs2095877700TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095877700TG
11	47353677	rs2095877700TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095877700TG
11	19213885	rs1850628800T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1850628800T
1	78383884	rs773500471T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126805765,NEXN;VARIANT_ID=rs773500471T
11	19207762	rs935867046A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs935867046A
11	47360133	rs1464769206C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1464769206C
14	23901010	rs1892956157A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892956157A
11	None	VCV000870305	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000870305
12	32949170	rs1956121988GA	G	GA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PKP2;VARIANT_ID=rs1956121988GA
11	47367922	rs2095894178G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095894178G
11	47367922	rs2095894178G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095894178G
11	47367305	rs2095893477A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095893477A
11	47367305	rs2095893477A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095893477A
11	47356632	rs2095880935C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095880935C
7	128497267	rs1809103569C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1809103569C
7	128489633	rs1465588989C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1465588989C
11	47365042	rs730880639A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880639A
7	128481252	rs1808318504CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808318504CA
7	128484931	rs1808489575G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808489575G
7	128495369	rs1554401581T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401581T
7	128478098	rs745495679T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs745495679T
11	47359030	rs2095883508C	CTCGA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095883508C
7	128482963	rs1808400111A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808400111A
12	111351125	rs774193307T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs774193307T
11	47371409	rs2095898532C	CTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095898532C
11	47365147	rs2095891411C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095891411C
7	128477804	rs1417082178T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1417082178T
7	128489417	rs1808708673T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808708673T
2	179476295	rs2056330918GTATC	G	GTATC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs2056330918GTATC
11	47354447	rs193922383C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922383C
14	23893265	rs1892592854C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892592854C
11	47369407	rs397516073A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516073A
11	47369407	rs397516073A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516073A
7	128486184	rs1808555459A	ACCTAC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808555459A
7	128486796	rs1808585056C	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808585056C
11	47360134	rs2095884984GAAGG	AGACGC	GAAGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095884984GAAGG
14	23900793	rs730880850G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880850G
7	128481619	rs1808336992T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808336992T
2	179441550	rs1330960948C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1330960948C
11	19209835	rs1187710437A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1187710437A
7	128490923	rs1808778979T	TCACGGTGAGGTATG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808778979T
11	47354885	rs2095879167T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095879167T
7	128492643	rs1808866340G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808866340G
7	128486105	rs1808550611C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808550611C
11	47365041	rs730880641G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880641G
11	47365041	rs730880641G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880641G
7	128493066	rs1808888920CG	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808888920CG
7	128486498	rs1342121466T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1342121466T
14	23895201	rs749007293T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs749007293T
7	128484212	rs761978559A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs761978559A
6	74190469	rs775623164T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs775623164T
7	128486218	rs1808557594A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808557594A
14	23900882	rs1892948780A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1892948780A
1	236898977	rs755492182T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTN2;VARIANT_ID=rs755492182T
7	128494491	rs1808965674CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808965674CT
11	47360094	rs1595844241T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595844241T
11	47360094	rs1595844241T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595844241T
11	19207808	rs1216811263T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1216811263T
11	47364183	rs2095889902G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095889902G
14	23886764	rs780625785G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs780625785G
17	37821993	rs2057249899C	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs2057249899C
17	37821993	rs2057249899C	CCA	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs2057249899C
7	128490538	rs1808761665C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1808761665C
7	128485217	rs1808508148A	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1808508148A
6	74176133	rs1030161382C	T	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1030161382C
14	23893276	rs779467831G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs779467831G
7	128488605	VCV000830847	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=VCV000830847
2	179438771	rs1709195189A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1709195189A
20	42815155	rs754529157T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 17;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=JPH2;VARIANT_ID=rs754529157T
11	47371459	rs1595849742A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595849742A
7	128481374	rs1585156450T	TTG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585156450T
11	47354817	rs1595841552T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595841552T
17	37821687	rs778851652A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs778851652A
17	37821687	rs778851652A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs778851652A
11	47359095	rs727503188C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503188C
11	47354378	rs1595841206AAAAT	A	AAAAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595841206AAAAT
11	47359240	rs1595843828T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595843828T
11	47359240	rs1595843828T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595843828T
11	47360940	rs1595844714CTGGG	C	CTGGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595844714CTGGG
11	47356762	rs1595842632A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595842632A
11	47374173	rs113709679T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113709679T
11	47374173	rs113709679T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113709679T
15	63336290	rs1596303148G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1596303148G
14	23894494	rs141414377G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs141414377G
14	23888797	rs727503249C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503249C
12	111353525	rs727504425G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs727504425G
3	48638548	rs201911056A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=UQCRC1;VARIANT_ID=rs201911056A
11	47355287	rs2095879705T	TGA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2095879705T
2	179438003	rs1198682781A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1198682781A
7	128498528	rs1585173340A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585173340A
14	23883211	rs1595070689G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1595070689G
11	47364893	rs1025692267T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1025692267T
11	47364893	rs1025692267T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1025692267T
11	47364697	rs113276889G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113276889G
11	47361954	rs1595845204A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595845204A
11	47361954	rs1595845204A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595845204A
11	47356144	rs1595842238C	CTCTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595842238C
11	47355113	rs1595841736A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595841736A
19	55668662	rs777702465T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs777702465T
11	47373030	rs1595850762AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595850762AC
X	100653045	rs1603037717G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs1603037717G
X	100653488	rs1603038411G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs1603038411G
1	201334396	rs1571627587A	ACTCATT	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs1571627587A
1	78399036	rs1571150562T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs1571150562T
11	47371357	rs1595849603A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595849603A
11	47369458	rs1595848628A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595848628A
2	179428334	rs1575649368A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1575649368A
1	201328779	rs748970759A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs748970759A
15	85406124	rs1450218521G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs1450218521G
15	85406124	rs1450218521G	GA	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 27;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs1450218521G
14	23884594	rs727505294T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs727505294T
11	47354170	rs1595841063C	CCGAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595841063C
7	128485100	rs773481064T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs773481064T
7	128481269	rs1585156327ACAAGGGGGATGGCTCCTGCGATGTG	A	ACAAGGGGGATGGCTCCTGCGATGTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585156327ACAAGGGGGATGGCTCCTGCGATGTG
2	179424890	rs72648224A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs72648224A
11	47364397	rs1595846344G	CC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595846344G
14	23885488	rs368722536A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs368722536A
7	128493553	rs1585168573GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585168573GC
7	128491511	rs1585166614G	GGTCT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585166614G
11	47370117	VCV000660700	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000660700
7	128496652	rs1585171628G	GCA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585171628G
14	23896931	rs1595085409A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1595085409A
14	23894198	rs730880741T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880741T
14	23883277	rs1595070747G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1595070747G
14	23886523	rs1246272841G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs1246272841G
11	47363647	rs730880694A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880694A
11	47354115	rs1299079662C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1299079662C
14	23896971	rs730880879G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880879G
11	47363576	rs1595845888G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595845888G
11	19213943	rs759305806T	TA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs759305806T
11	47364594	rs1595846475A	ACACTTCTCGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595846475A
11	47358967	rs1595843549AGGGCT	A	AGGGCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595843549AGGGCT
7	128486459	rs1218299104A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1218299104A
11	47359105	rs1595843758C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595843758C
1	201334767	rs746297911A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs746297911A
7	128481607	rs1585156701T	AAGCTCTATGCCC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585156701T
7	128496685	rs540386120A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs540386120A
11	47353637	rs1595840648C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595840648C
11	47353637	rs1595840648C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595840648C
11	47371629	rs1595849931A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595849931A
2	179433713	rs1205409465AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1205409465AG
7	128488763	rs1585163755T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585163755T
7	128475581	rs1585151331A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585151331A
7	128486518	rs1346981294T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1346981294T
7	128498119	rs1554402003C	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554402003C
7	128482429	rs1585157354A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1585157354A
7	128494737	rs1585169973T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585169973T
7	128494622	rs1585169831T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585169831T
14	23899059	rs397516088A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516088A
7	128494628	rs1420394583A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1420394583A
7	128483010	rs113972676C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs113972676C
2	179393094	rs1477669354A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1477669354A
7	128492705	rs1585167678AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs1585167678AG
11	47362743	rs1595845565T	TGTAGTCAGCCTCGTCGGCAGGTGTGAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595845565T
20	33588242	rs1600477808C	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs1600477808C
20	33570359	rs1050997719A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs1050997719A
20	33570339	rs764950910ACGGGC	A	ACGGGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs764950910ACGGGC
20	33588821	rs1600480573C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs1600480573C
20	33587083	rs1417887060A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs1417887060A
20	33583157	rs1600462474C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs1600462474C
20	33577886	rs1600448065C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7B;VARIANT_ID=rs1600448065C
6	74171670	rs1582666067G	GC	G	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1582666067G
4	1962801	rs772470710A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NSD2;VARIANT_ID=rs772470710A
11	47364470	rs1595846398G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595846398G
11	47359017	rs1595843640C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595843640C
7	128491650	rs1585166795A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1585166795A
14	23896051	rs1595084560T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1595084560T
14	23900677	rs3218713A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713A
1	78399141	rs1557988499T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs1557988499T
14	23894132	rs397516154G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516154G
11	47356731	rs1565624196G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565624196G
15	35084359	rs1566967399T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs1566967399T
12	111348949	rs1566147422C	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs1566147422C
11	19207814	rs1565050709A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1565050709A
1	78383386	rs765396527C	CAAAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs765396527C
2	179400235	rs766265889A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs766265889A
11	47363688	rs1565627615C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565627615C
7	128489402	rs1563000044T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1563000044T
7	128486411	rs1562998062T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562998062T
7	128490936	rs371167779G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs371167779G
11	47359091	rs1419032418T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1419032418T
11	47359091	rs1419032418T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1419032418T
11	None	VCV000619292	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000619292
7	151269779	rs1563161306G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs1563161306G
14	23894081	rs1566531421G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1566531421G
14	23898171	rs730880872T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880872T
14	23898246	rs730880870A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880870A
14	23899809	rs1566536418T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566536418T
14	23899816	rs1566536436G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566536436G
11	47354194	rs1565622703TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565622703TG
11	47354881	rs1565623216T	TTGTCTGCGGGAGAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565623216T
11	47357424	rs1265248322T	TCA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1265248322T
11	47357427	rs727504314T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504314T
11	47357551	rs190765116A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs190765116A
11	47358999	rs1595843598CCG	C	CCG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1595843598CCG
11	47360098	rs1565625795A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565625795A
11	47364444	rs1565628078AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565628078AC
11	47364697	rs113276889A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113276889A
11	47370036	rs774316050T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs774316050T
11	47370036	rs774316050T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs774316050T
11	47372115	rs1565631381C	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565631381C
11	47372145	rs1565631424G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565631424G
1	78392512	rs771262904T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs771262904T
2	179395919	rs534484592C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs534484592C
17	37821613	rs1567864804G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1567864804G
7	128498475	rs1563006133A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563006133A
14	23898506	rs1566535410C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566535410C
14	23898506	rs1566535410C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566535410C
7	128470672	VCV000584412	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1,LOC129999273;VARIANT_ID=VCV000584412
14	23894025	rs730880751A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880751A
11	47372150	rs1565631430C	CATGGGCTCTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565631430C
7	128497391	rs1563005607A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563005607A
11	47363601	rs1565627536C	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565627536C
14	23896923	rs727504294G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504294G
11	47360070	rs1565625777CCGAT	C	CCGAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565625777CCGAT
7	128480212	rs763330423C	CAAGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs763330423C
11	47359276	rs1565625473TC	T	TC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565625473TC
14	23894190	rs1566531657G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1566531657G
2	179468996	rs747236787A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs747236787A
7	128486190	rs766330686T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs766330686T
11	47354498	rs1565622952T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565622952T
11	47359280	rs187830361T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs187830361T
19	55665543	rs1568858210G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs1568858210G
7	128488655	rs1562999451T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562999451T
14	23894015	rs1566531303G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1566531303G
2	179466064	rs1483931960A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1483931960A
1	201328349	rs367785431T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs367785431T
11	47356629	rs1565624090TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565624090TA
14	23895200	rs1224554825T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1224554825T
14	23898550	rs1566535491C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566535491C
2	179456783	rs1559598775A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806424,TTN,TTN-AS1;VARIANT_ID=rs1559598775A
6	74207523	rs1561954433T	TC	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1561954433T
7	128493852	rs1563003153A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563003153A
2	179474501	rs1060500503A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1060500503A
7	128484710	rs749889670G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs749889670G
14	23894026	rs1060505018G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060505018G
14	23894026	rs1060505018G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060505018G
2	179453401	rs1559561666TGC	T	TGC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1559561666TGC
11	47361265	rs1565626409AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565626409AC
11	47368976	rs767698543A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs767698543A
11	47368976	rs767698543A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs767698543A
14	23895201	rs749007293C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs749007293C
11	47369032	rs1565629792C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565629792C
11	47369032	rs1565629792C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565629792C
7	128487792	rs1562998858G	GGGAA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562998858G
14	23900682	rs1566537070T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566537070T
12	111352004	rs397516399T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs397516399T
11	47363634	rs1565627566CTAAACCTCATCCTTCTCATCTCTAAAATGACGATGCTGAGGTGACCGCTCCAGAGGGTACTGAGAGGGTCATACGGGCCTGGTGAGCATCACCACCCCTCAGACACTTGAGGTTCCTTATGTGCACTGCACCATCACAGGCAAACATGGCACACACAGGCACACGTGTTTTCACATGCCCACATGCACCCAGACACGTGCGCACCAGCGCCCATGGGCCCACACGCCCTCCACAGGGATTCACGCCACACCCACACACCCTCCCGAGCTCAATGGCTCTGCCCTGCCCTGCAGAAAAGAAGCTGGAGGTGTACCAGAGCATCGCAGACCTGATGGTGGGCGCAAAGGACCAGCAGCCACAGTAGCTTGGCCTGGGGGAGCAGGGTGCGGGCGGTGGGGTGGCCGGGGCTGAGGGGTGGTGCTCAGCCTTTCAGAAGAAGCTGGAGCCGGCCTACCAGGTGAGCAAAGGCCACAAGATCCGGCTGACCGTGGAACTGGCTGACCATGACGCTGAGGTCAAATGGCTCAAGAATGGCCAGGAGATCCAGATGAGCGGCAGGTGCAGCCTGGGGTGGGGAGGGGGGCTCGGGTGGAGCAGCCACAGTAGCTTGGCCTGGGGGAGCAGGG	ACATTTGAACACCGC	CTAAACCTCATCCTTCTCATCTCTAAAATGACGATGCTGAGGTGACCGCTCCAGAGGGTACTGAGAGGGTCATACGGGCCTGGTGAGCATCACCACCCCTCAGACACTTGAGGTTCCTTATGTGCACTGCACCATCACAGGCAAACATGGCACACACAGGCACACGTGTTTTCACATGCCCACATGCACCCAGACACGTGCGCACCAGCGCCCATGGGCCCACACGCCCTCCACAGGGATTCACGCCACACCCACACACCCTCCCGAGCTCAATGGCTCTGCCCTGCCCTGCAGAAAAGAAGCTGGAGGTGTACCAGAGCATCGCAGACCTGATGGTGGGCGCAAAGGACCAGCAGCCACAGTAGCTTGGCCTGGGGGAGCAGGGTGCGGGCGGTGGGGTGGCCGGGGCTGAGGGGTGGTGCTCAGCCTTTCAGAAGAAGCTGGAGCCGGCCTACCAGGTGAGCAAAGGCCACAAGATCCGGCTGACCGTGGAACTGGCTGACCATGACGCTGAGGTCAAATGGCTCAAGAATGGCCAGGAGATCCAGATGAGCGGCAGGTGCAGCCTGGGGTGGGGAGGGGGGCTCGGGTGGAGCAGCCACAGTAGCTTGGCCTGGGGGAGCAGGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565627566CTAAACCTCATCCTTCTCATCTCTAAAATGACGATGCTGAGGTGACCGCTCCAGAGGGTACTGAGAGGGTCATACGGGCCTGGTGAGCATCACCACCCCTCAGACACTTGAGGTTCCTTATGTGCACTGCACCATCACAGGCAAACATGGCACACACAGGCACACGTGTTTTCACATGCCCACATGCACCCAGACACGTGCGCACCAGCGCCCATGGGCCCACACGCCCTCCACAGGGATTCACGCCACACCCACACACCCTCCCGAGCTCAATGGCTCTGCCCTGCCCTGCAGAAAAGAAGCTGGAGGTGTACCAGAGCATCGCAGACCTGATGGTGGGCGCAAAGGACCAGCAGCCACAGTAGCTTGGCCTGGGGGAGCAGGGTGCGGGCGGTGGGGTGGCCGGGGCTGAGGGGTGGTGCTCAGCCTTTCAGAAGAAGCTGGAGCCGGCCTACCAGGTGAGCAAAGGCCACAAGATCCGGCTGACCGTGGAACTGGCTGACCATGACGCTGAGGTCAAATGGCTCAAGAATGGCCAGGAGATCCAGATGAGCGGCAGGTGCAGCCTGGGGTGGGGAGGGGGGCTCGGGTGGAGCAGCCACAGTAGCTTGGCCTGGGGGAGCAGGG
7	128489383	rs774945928T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs774945928T
7	128482754	rs112903432C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs112903432C
14	23894201	rs773009513T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs773009513T
11	47365091	rs1565628486G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565628486G
11	47369406	rs397516076T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516076T
14	23894101	rs1343088568T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1343088568T
11	47364415	rs1565628062A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565628062A
11	47372148	rs1565631428A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1565631428A
7	128491399	rs1563001456T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563001456T
1	201332507	rs1558225569T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs1558225569T
7	128477312	rs1562991776A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562991776A
7	128470838	rs1562988883TCT	C	TCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562988883TCT
7	128491507	rs1563001548A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563001548A
11	47354115	rs1299079662G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1299079662G
7	128498502	rs1563006160A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1563006160A
14	23869917	rs1566513862T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 14;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH6;VARIANT_ID=rs1566513862T
14	23893267	rs1566530698C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1566530698C
14	23894573	rs1348730180T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1348730180T
11	19207804	rs1554967541A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1554967541A
11	19213940	rs1554968138T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1554968138T
7	128481565	rs1446694237T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1446694237T
7	128491536	rs1554400700CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554400700CA
7	128475471	rs1554397197A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554397197A
7	128496948	rs1554401837G	GGTCCTGGGCTCGA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401837G
7	128498209	rs1554402015C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs1554402015C
7	128477557	rs755583250T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs755583250T
7	128489593	rs1554400242C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554400242C
7	128495297	rs1554401561C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401561C
7	128480657	rs199976790A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs199976790A
7	128495369	rs1554401581A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401581A
7	128496910	rs1554401830ATGCT	A	ATGCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401830ATGCT
1	78401599	rs1553240600TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs1553240600TA
1	201334406	rs1553282545T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs1553282545T
12	111352091	rs104894369A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs104894369A
11	47354097	VCV000525139	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000525139
11	47353402	VCV000525136	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000525136
11	46880514	VCV000525135	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MADD-AS1,ARFGAP2,CSTPP1,MADD,ACP2,DDB2,LRP4,MYBPC3,NR1H3,PACSIN3,PSMC3,RAPSN,SLC39A13,SPI1;VARIANT_ID=VCV000525135
11	47357408	VCV000525134	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000525134
11	47363541	rs1555122053T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122053T
11	47363541	rs1555122053T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122053T
14	23894503	rs1555337794G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1555337794G
11	47355517	rs1555120651A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555120651A
11	47371474	rs397516056T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516056T
11	47371474	rs397516056T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516056T
11	47372790	rs868819340A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs868819340A
19	55667661	rs1245885836A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs1245885836A
14	23885518	rs1555336492G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs1555336492G
14	23898536	rs1555338378A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338378A
14	23901855	rs1555338758T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338758T
2	179417634	rs376543931T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs376543931T
11	47372861	rs1555123743AA	G	AA	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123743AA
11	47372861	rs1555123743AA	G	AA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123743AA
17	37821644	rs1555606959CG	C	CG	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1555606959CG
17	37821644	rs1555606959CG	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs1555606959CG
11	47360231	rs727504334A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504334A
11	47368984	rs1555122928T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122928T
11	47368984	rs1555122928T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122928T
11	47364296	rs397515903G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515903G
2	179435222	rs1553603036CAACA	C	CAACA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1553603036CAACA
2	179433954	rs1553601017AT	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1553601017AT
14	23896932	rs121913626A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913626A
11	47372053	rs1555123597CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123597CT
11	47371557	rs1555123473A	ACACTCACC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123473A
11	19213984	rs1554968150C	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1554968150C
11	19213984	rs1554968150C	CCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs1554968150C
11	47371589	rs1555123496G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123496G
11	47354781	rs767039057T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs767039057T
11	47354846	rs1555120529CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555120529CA
14	23897094	rs771831848C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs771831848C
11	47354744	rs1298025872A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1298025872A
14	23894039	rs1555337701G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1555337701G
11	47359092	rs1555121247A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555121247A
11	47364158	rs1555122156C	CCCCCGCTAGTGCACAGTGCATAGTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122156C
X	100653907	rs869312381G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs869312381G
14	23894211	rs1555337763G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1555337763G
11	47354114	rs1555120258T	TA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555120258T
11	47354525	rs727504305G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504305G
2	179477578	rs1471414348A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1471414348A
11	47360120	rs774521272CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs774521272CA
14	23900190	rs1555338578G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338578G
2	179392275	rs1009131948A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1009131948A
11	47371589	rs397516053A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516053A
11	47368177	rs767239679T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs767239679T
7	128480109	rs1420159591T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1420159591T
11	47367758	VCV000517190	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000517190
15	63356292	rs1555410433G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1555410433G
14	23896483	rs1555338080G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338080G
14	23898488	rs3218714C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714C
15	63351847	rs1555408679G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1555408679G
2	179456938	rs974671846T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806424,TTN,TTN-AS1;VARIANT_ID=rs974671846T
15	85382318	rs200889953T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs200889953T
15	85382318	rs200889953T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 27;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs200889953T
15	85401691	rs745688425G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs745688425G
15	85401691	rs745688425G	GC	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 27;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ALPK3;VARIANT_ID=rs745688425G
2	179396150	rs770878165A	AAC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs770878165A
7	128491594	rs764539989A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs764539989A
11	47362772	rs764743402TCG	T	TCG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs764743402TCG
11	47364248	rs1555122188C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122188C
2	179395292	rs1250336644A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC129935182,TTN,TTN-AS1;VARIANT_ID=rs1250336644A
1	201331122	rs397516476T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516476T
2	179440096	rs1553612999C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1553612999C
6	74191964	rs771939280T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs771939280T
2	179400456	rs1260821931T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1260821931T
19	55665541	rs1393946566A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs1393946566A
2	179428202	rs869178171A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs869178171A
11	47364620	rs1432810664A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1432810664A
11	47364620	rs1432810664A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1432810664A
11	47359018	rs373792537C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373792537C
11	47359018	rs373792537C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373792537C
6	74191931	rs1033653237T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1033653237T
6	74189683	rs1554148965C	A	C	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs1554148965C
2	179442512	rs1213930919A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1213930919A
7	128477522	rs1554397506T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554397506T
7	128496690	rs1554401780C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401780C
7	128496614	rs1554401756T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554401756T
7	128477309	rs1554397464T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554397464T
7	128494715	rs748416758T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs748416758T
7	128489028	rs1402879259TCGTCACAA	T	TCGTCACAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1402879259TCGTCACAA
7	128488746	rs1554400021A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554400021A
7	128486183	rs1554399513CACCT	C	CACCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554399513CACCT
7	128482835	rs1554398674C	CGCTTCTCTGCAGGCGACGTGAGCATCG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554398674C
7	128484167	rs1554399014A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554399014A
7	128480729	rs111452612A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs111452612A
7	128480216	rs111806457G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs111806457G
7	128480180	rs1554398092C	CAGCGGGG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1554398092C
7	128494697	rs867808948A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs867808948A
7	128492908	rs1554400962A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554400962A
7	128488670	rs774263134A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs774263134A
1	201332459	rs377157235C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs377157235C
2	179418467	rs1179247052T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1179247052T
2	179424433	rs1553560951C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1553560951C
2	179444846	rs1476017129C	CAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1476017129C
2	179446936	rs1553627403G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1553627403G
15	63336259	rs1060501866T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1060501866T
14	23900792	rs1555338658C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338658C
14	23885419	rs1555336467T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs1555336467T
14	23887453	rs397516202A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516202A
14	23893327	rs397516165G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516165G
14	23894063	rs758891557A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs758891557A
14	23894102	rs397516157C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516157C
14	23895188	rs1555337912T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555337912T
11	47371472	rs1555123438ACCTG	A	ACCTG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123438ACCTG
11	47372141	rs1555123629A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123629A
11	47372150	rs1555123633CATGG	C	CATGG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123633CATGG
11	47357491	rs1555120937GCCGCCACTTGAGGGAGACCGTGGTGT	G	GCCGCCACTTGAGGGAGACCGTGGTGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555120937GCCGCCACTTGAGGGAGACCGTGGTGT
11	47358975	rs1555121172G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555121172G
11	47359032	rs397515969A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515969A
11	47367758	rs794727046T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs794727046T
11	47368957	VCV000454298	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000454298
11	47353402	VCV000454297	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000454297
14	23900202	rs1555338582G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338582G
11	47359018	rs373792537T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373792537T
14	23899070	rs1555338462G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338462G
11	47360239	rs773882783C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs773882783C
11	47361201	rs1444727212T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1444727212T
11	47361201	rs1444727212T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1444727212T
17	37821635	rs778568339GCGAGGTGT	G	GCGAGGTGT	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs778568339GCGAGGTGT
17	37821635	rs778568339GCGAGGTGT	G	GCGAGGTGT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs778568339GCGAGGTGT
6	74191826	rs200583827T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs200583827T
11	47371324	rs730880621T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880621T
11	47371324	rs730880621T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880621T
11	47360231	rs1555121488C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555121488C
11	47360231	rs1555121488C	CT	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555121488C
11	47360231	rs1555121488C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555121488C
11	47354184	rs1555120300A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555120300A
11	47362756	rs1555121924T	GTCGGCAG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555121924T
14	23893130	rs1446657813T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1446657813T
7	128491542	rs1554400703A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs1554400703A
7	128478037	rs532143625G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs532143625G
14	23898221	rs1555338319G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1555338319G
11	47357446	rs1555120920A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555120920A
1	201328755	rs1553279294C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs1553279294C
7	140434568	rs1131692058A	AATCTAC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=BRAF;VARIANT_ID=rs1131692058A
7	128485066	rs1131692185CT	GC	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1131692185CT
11	47364129	rs121909374A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909374A
11	47371341	rs1555123389T	TAGCTGTCGTGC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555123389T
2	179435195	rs1131691542A	AT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1131691542A
2	179470423	rs1131691381A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1131691381A
15	63354412	rs1555409659A	AGTACTC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs1555409659A
7	128485076	rs1114167361T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1114167361T
11	47364812	rs1114167419A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1114167419A
2	179436483	rs1064796390CTTA	GTTAGTCAG	CTTA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1064796390CTTA
11	47353710	rs1064796231G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1064796231G
2	179477182	rs1064796139C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1064796139C
2	179443358	rs1064796112G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806423,TTN,TTN-AS1;VARIANT_ID=rs1064796112G
7	128484307	rs1064795229C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1064795229C
7	128481358	rs770606675T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs770606675T
7	128486043	rs781135153C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs781135153C
19	55668006	rs772607683AT	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs772607683AT
11	47357563	rs977277400G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs977277400G
2	179400887	rs1064793560T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1064793560T
11	47360220	rs1064793429T	TCA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1064793429T
14	23889159	rs529700838C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs529700838C
14	23891466	rs747198710G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs747198710G
14	23894202	rs1064793206A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1064793206A
11	47355173	rs1064793202GTT	G	GTT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1064793202GTT
11	47370000	rs771929829T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs771929829T
11	47372982	rs745811346C	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs745811346C
2	179418510	rs1553543413AT	A	AT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1553543413AT
11	47360874	rs1060499604A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060499604A
11	47360874	rs1060499604A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060499604A
14	23894026	rs1060505018A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060505018A
14	23894026	rs1060505018A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs1060505018A
12	111348623	VCV000417460	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=VCV000417460
11	47371325	VCV000417402	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000417402
11	47353396	VCV000417401	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000417401
6	74191952	rs748152539T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs748152539T
11	47354126	rs1060501484A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501484A
11	47372845	rs730880698T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880698T
11	47372823	rs1064792936CCTCC	TGG	CCTCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1064792936CCTCC
11	47356590	rs1060501483G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501483G
11	47360071	rs36211723G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs36211723G
11	47358971	rs1060501481CTT	C	CTT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501481CTT
11	47353771	rs1060501480T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501480T
11	47373016	rs1060501479GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501479GC
11	47360099	rs1060501478G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501478G
11	47355197	rs1060501475G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501475G
11	47360114	rs1060501474T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501474T
11	47360114	rs1060501474T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060501474T
14	23898513	rs1060501452T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1060501452T
14	23898513	rs1060501452T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1060501452T
14	23889409	rs1064792935GCCTCCAGCTCCT	G	GCCTCCAGCTCCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1064792935GCCTCCAGCTCCT
14	23895001	rs1060501448G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1060501448G
14	23897064	rs1060501443G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1060501443G
14	23895201	rs749007293A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs749007293A
2	179438027	rs751319893TAAGA	T	TAAGA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs751319893TAAGA
2	179434205	rs545954490A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs545954490A
2	179417766	rs1060500457T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1060500457T
2	179411339	rs1060500435A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs1060500435A
12	111348980	rs199474813A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs199474813A
11	47354749	rs1060499673G	GTC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1060499673G
14	23894494	rs141414377T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs141414377T
2	179463631	rs72646828A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs72646828A
14	23894968	rs1057520814T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1057520814T
11	47364571	rs727503204G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503204G
19	55668416	rs1057520417C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs1057520417C
14	23883216	rs753392652T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs753392652T
14	23883216	rs753392652T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs753392652T
14	23894999	rs727504299T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504299T
7	74203683	rs1057519503A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC106029312,NCF1;VARIANT_ID=rs1057519503A
3	122003250	rs1057518933A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CASR;VARIANT_ID=rs1057518933A
2	179397981	rs760768093T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs760768093T
14	23895243	rs1057518560T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs1057518560T
11	47354818	rs779650200T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs779650200T
11	47359319	rs1057518030T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1057518030T
2	179396689	rs1057518003A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs1057518003A
14	23884226	rs757803046T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs757803046T
11	19207813	rs902082118A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs902082118A
11	47372084	rs1057517767A	AGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1057517767A
11	47372805	rs1057517766T	TGA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1057517766T
12	2675632	rs1057517711A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CACNA1C;VARIANT_ID=rs1057517711A
17	37821678	rs141019458A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs141019458A
17	37821678	rs141019458A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs141019458A
17	37821653	rs886044421ACTGTGAG	A	ACTGTGAG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs886044421ACTGTGAG
17	37821653	rs886044421ACTGTGAG	A	ACTGTGAG	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs886044421ACTGTGAG
17	37821715	rs779699520T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs779699520T
17	37821715	rs779699520T	G	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs779699520T
2	179597615	rs772235481A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs772235481A
2	179444665	rs758279518T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs758279518T
11	47368581	rs587776700T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587776700T
7	128484099	rs886037830T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs886037830T
15	63349193	rs754664923A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs754664923A
1	201334421	rs778426227A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs778426227A
14	23889203	rs886039090T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs886039090T
11	47357438	rs886038822T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886038822T
11	47367919	rs886037902T	TCC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886037902T
11	47367919	rs886037902T	TCC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886037902T
11	47372123	rs886037901CTCAG	C	CTCAG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886037901CTCAG
11	47364433	rs886037900G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886037900G
11	47364433	rs886037900G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886037900G
7	128488980	rs879255639T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs879255639T
7	128475395	rs1562991002C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562991002C
7	128494682	rs1563003848A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC-AS1,FLNC;VARIANT_ID=rs1563003848A
7	128488649	rs1562999443A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs1562999443A
2	179444577	rs753948675G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs753948675G
2	179421814	rs878854428T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs878854428T
2	179531966	rs878854299A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs878854299A
14	23900662	rs878853842T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs878853842T
11	47363691	rs878853831C	CACCTCCAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs878853831C
11	47364686	rs397515894CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515894CA
14	23886479	rs876657884T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs876657884T
14	23886479	rs876657884T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs876657884T
14	23886479	rs876657884T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs876657884T
14	23894048	rs36211715A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs36211715A
15	63335068	rs876661210T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs876661210T
14	23899073	rs876661150C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs876661150C
14	23887552	rs730880787C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880787C
14	23900849	rs876657887A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs876657887A
14	23887512	rs750836033T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs750836033T
11	47369405	rs727503213A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503213A
1	201332477	rs727503512A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727503512A
11	47354231	rs876657706G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs876657706G
11	47356708	rs876657705C	CA	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs876657705C
11	47356708	rs876657705C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs876657705C
11	47364393	rs876657703GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs876657703GC
11	47367773	rs876657702A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs876657702A
11	47354117	VCV000228366	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000228366
X	119581628	VCV000228268	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=VCV000228268
1	201334414	rs869312881T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs869312881T
2	179411203	rs869312121A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs869312121A
2	179426483	rs869312119A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs869312119A
2	179437750	rs869312115T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs869312115T
2	179603088	rs869312099T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs869312099T
2	179413187	rs72648250A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs72648250A
2	179417723	rs869312081A	ATAAT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs869312081A
2	179450018	rs768345594A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs768345594A
2	179452435	rs764243269A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs764243269A
2	179393848	rs869312069C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs869312069C
2	179425769	rs770038577A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs770038577A
2	179482115	rs373040154T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs373040154T
3	12645690	rs869025501A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=RAF1;VARIANT_ID=rs869025501A
1	78407821	rs869025492A	AAG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs869025492A
3	46901063	rs869025485T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs869025485T
14	23898517	rs869025477A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs869025477A
11	47353621	rs869025470G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025470G
11	47354526	rs869025469G	T	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025469G
11	47354526	rs869025469G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025469G
11	47355254	rs869025468GC	G	GC	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025468GC
11	47355254	rs869025468GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025468GC
11	47362552	rs869025467G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025467G
11	47363708	rs869025466T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025466T
11	47365097	rs869025465T	TGGTCAGCCAGTTCCAC	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025465T
11	47365097	rs869025465T	TGGTCAGCCAGTTCCAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025465T
11	47365097	rs869025465T	TGGTCAGCCAGTTCCAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025465T
11	47371627	rs869025464C	CCA	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025464C
11	47372101	rs869025463C	CT	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025463C
11	47372932	rs869025462CTCATCA	GCTGAT	CTCATCA	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025462CTCATCA
11	47355135	rs869025461A	T	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025461A
11	47355135	rs869025461A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025461A
11	47355135	rs869025461A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025461A
11	47360925	rs869025460C	CT	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025460C
11	47364178	rs397515910T	A	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515910T
11	47364178	rs397515910T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515910T
11	47372853	rs869025459A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025459A
11	47372853	rs869025459A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs869025459A
X	135292105	rs869025431C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FHL1;VARIANT_ID=rs869025431C
11	19213946	rs869025378A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs869025378A
11	19213883	rs746990436T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs746990436T
1	156106075	rs1057515421T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LMNA;VARIANT_ID=rs1057515421T
9	139313082	rs768643552A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PMPCA;VARIANT_ID=rs768643552A
9	139313299	rs753611141A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PMPCA;VARIANT_ID=rs753611141A
11	47359001	rs730880569T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880569T
14	23897067	rs730880930G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880930G
11	47372919	rs864622224A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs864622224A
11	None	VCV000219725	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=VCV000219725
11	47368616	rs864622197T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs864622197T
11	47368616	rs864622197T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs864622197T
11	19206558	rs761507504T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs761507504T
11	19206558	rs761507504T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs761507504T
11	47353723	rs863225272C	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225272C
11	47364478	rs863225271C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225271C
11	47364478	rs863225271C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225271C
14	23862178	rs863225269TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH6;VARIANT_ID=rs863225269TG
11	47364621	rs190228518T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs190228518T
11	47364621	rs190228518T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs190228518T
10	75854207	rs863225121T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 15;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=VCL;VARIANT_ID=rs863225121T
1	201331098	rs863225120G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs863225120G
1	201328760	rs863225119A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs863225119A
11	47354440	rs863225114CG	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225114CG
11	47354775	rs863225113T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225113T
11	47354775	rs863225113T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225113T
11	47359278	rs863225112T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225112T
11	47359278	rs863225112T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225112T
11	47372854	rs863225111CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225111CT
11	47372152	rs863225109T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225109T
11	47353774	rs863225107C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225107C
11	47353774	rs863225107C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225107C
11	47359283	rs863225106A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225106A
11	47359283	rs863225106A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225106A
11	47358993	rs863225105C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225105C
11	47358993	rs863225105C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225105C
11	47357494	rs863225104GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863225104GC
11	47364481	rs749310275A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs749310275A
14	23894133	rs863225103C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs863225103C
14	23894133	rs863225103C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs863225103C
14	23894623	rs863225102T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs863225102T
14	23900668	rs727505202C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727505202C
14	23897808	rs730880876G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880876G
14	23895231	rs863225101C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225101C
14	23895231	rs863225101C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225101C
14	23886150	rs767148171C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs767148171C
14	23884341	rs369940645T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs369940645T
14	23894112	rs863225099T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs863225099T
14	23889422	rs863225098T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225098T
14	23889135	rs863225096G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863225096G
14	23894002	rs863225095T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs863225095T
11	47359131	rs863224899T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863224899T
11	47359131	rs863224899T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863224899T
11	19207840	rs863224716A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs863224716A
14	23897057	rs863224645C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs863224645C
11	47361204	rs863224483A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863224483A
11	47361204	rs863224483A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs863224483A
14	23887557	rs797045097T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs797045097T
14	23887557	rs797045097T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs797045097T
4	159606337	rs147219158A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ETFDH;VARIANT_ID=rs147219158A
2	179435531	rs794729382A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729382A
2	179641961	rs756433029C	CTTTCA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC101927055,TTN;VARIANT_ID=rs756433029C
2	179407450	rs748382770GTA	G	GTA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs748382770GTA
2	179407530	rs794729365CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729365CT
2	179424467	rs794729354T	TAGTAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729354T
2	179427785	rs794729351T	TAGCACTTGCA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729351T
2	179435717	rs794729340A	ATTCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729340A
2	179400115	rs794729305A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729305A
2	179428220	rs779874042A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs779874042A
2	179432681	rs794729289A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729289A
2	179436521	rs794729285A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729285A
2	179437013	rs794729284A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729284A
2	179441812	rs794729281A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs794729281A
2	179449279	rs794729280A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729280A
2	179454897	rs794729278A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs794729278A
6	118880145	rs794729138CCT	C	CCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CEP85L,PLN;VARIANT_ID=rs794729138CCT
1	78390883	rs794729088T	TAAAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=NEXN;VARIANT_ID=rs794729088T
2	179393000	rs112188483T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs112188483T
2	179455770	rs797044692TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs797044692TA
11	47359086	rs775404728A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs775404728A
11	47359086	rs775404728A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs775404728A
14	23885359	rs730880809G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs730880809G
14	23885313	rs121913648A	ATCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs121913648A
17	37822268	rs773317399T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs773317399T
1	236882284	rs786204949T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 23 WITH OR WITHOUT VENTRICULAR NONCOMPACTION;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTN2;VARIANT_ID=rs786204949T
14	23894580	rs2069544T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2069544T
11	47364460	rs786204339A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204339A
11	47364460	rs786204339A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204339A
11	47364865	rs786204336T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204336T
11	47364865	rs786204336T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204336T
11	47370045	rs786204329AGTGAAGGCAGGCTGGGCATCGGTGAT	A	AGTGAAGGCAGGCTGGGCATCGGTGAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204329AGTGAAGGCAGGCTGGGCATCGGTGAT
11	47370045	rs786204329AGTGAAGGCAGGCTGGGCATCGGTGAT	A	AGTGAAGGCAGGCTGGGCATCGGTGAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs786204329AGTGAAGGCAGGCTGGGCATCGGTGAT
11	47370092	rs397516068A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516068A
15	63335090	rs730881151T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs730881151T
15	63335090	rs730881151T	G	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs730881151T
15	63353950	rs730881141T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs730881141T
1	201328750	rs111377893G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs111377893G
1	201334423	rs730881122G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881122G
1	201328344	rs730881116T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881116T
1	201328344	rs730881116T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881116T
1	201333463	rs730881115C	CG	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881115C
1	201331144	rs730881106A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881106A
1	201332522	rs730881103C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881103C
1	201333463	rs730881101T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs730881101T
1	201334764	rs397516451T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516451T
19	55663239	rs730881091T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs730881091T
19	55665526	rs730881071A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs730881071A
19	55665540	rs730881069T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs730881069T
3	52486169	rs730881065C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 13;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs730881065C
3	52485431	rs730881061C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs730881061C
3	52485431	rs730881061C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 13;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs730881061C
3	46900999	rs730880162A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs730880162A
12	111353585	rs730880946C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs730880946C
14	23884408	rs730880935G	GTTC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880935G
14	23897067	rs730880930C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880930C
14	23897716	rs730880929G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880929G
14	23899843	rs730880923T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880923T
14	23900683	rs730880922C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880922C
14	23901856	rs730880920T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880920T
14	23884619	rs730880916T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs730880916T
14	23884965	rs730880914T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs730880914T
14	23885517	rs730880912A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs730880912A
14	23891477	rs730880903A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880903A
14	23894102	rs397516157T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516157T
14	23894113	rs730880899G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880899G
14	23894582	rs730880895T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880895T
14	23894582	rs730880895T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880895T
14	23896018	rs730880883T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880883T
14	23896018	rs730880883T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880883T
14	23897808	rs730880876T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880876T
14	23897810	rs730880875C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880875C
14	23898246	rs730880870T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880870T
14	23898256	rs370310929C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs370310929C
14	23900163	rs730880856G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880856G
14	23900675	rs397516268A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516268A
14	23900678	rs730880852C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880852C
14	23901857	rs730880839C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880839C
14	23901919	rs730880834T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880834T
14	23902315	rs730880832T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880832T
14	23902913	rs730880826G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880826G
14	23882997	rs539290591A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs539290591A
14	23883032	rs397516253T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516253T
14	23884229	rs730880822T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880822T
14	23884305	rs145734640A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs145734640A
14	23884353	rs730880818T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880818T
14	23884618	rs730880813C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs730880813C
14	23884966	rs377461670A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs377461670A
14	23885487	rs730880806T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs730880806T
14	23886765	rs730880800A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs730880800A
14	23886879	rs730880793A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880793A
14	23887465	rs730880790G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880790G
14	23887465	rs730880790G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880790G
14	23891462	rs730880770T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880770T
14	23894025	rs730880751G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880751G
14	23894064	rs730880749C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880749C
14	23894064	rs730880749C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880749C
14	23894160	rs730880746G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs730880746G
14	23894567	rs727503258A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503258A
14	23894992	rs727504241A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504241A
14	23894999	rs727504299A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504299A
14	23894999	rs727504299A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504299A
11	47365103	rs730880724GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880724GC
11	47367763	rs730880723CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880723CT
11	47372134	rs730880721C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880721C
11	47354387	rs730880720CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880720CT
11	47354387	rs730880720CT	C	CT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880720CT
11	47354747	rs730880719T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880719T
11	47355103	rs730880718C	CGCACCAACAACCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880718C
11	47359271	rs730880714G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880714G
11	47363554	rs730880713G	GAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880713G
11	47364479	rs727503203AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503203AG
11	47365078	rs397515890T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515890T
11	47371654	rs730880704C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880704C
11	47371654	rs730880704C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880704C
11	47371654	rs730880704C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880704C
11	47371660	rs730880703C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880703C
11	47353724	rs730880702G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880702G
11	47353724	rs730880702G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880702G
11	47354191	rs730880699A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880699A
11	47372845	rs730880698C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880698C
11	47372845	rs730880698C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880698C
11	47359115	rs375675796A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375675796A
11	47363636	rs730880695G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880695G
11	47367819	rs730880686A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880686A
11	47368997	rs730880684G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880684G
11	47368997	rs730880684G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880684G
11	47371392	rs730880681C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880681C
11	47371613	rs730880680G	GGT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880680G
11	47371616	rs730880679C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880679C
11	47368180	rs730880678CAGTT	C	CAGTT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880678CAGTT
11	47371619	rs730880677C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880677C
11	47371619	rs730880677C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880677C
11	47353678	rs730880676G	GCAGACATAGATGCCC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880676G
11	47354373	rs730880675G	GGGATAAAGAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880675G
11	47354445	rs730880674A	AAGT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880674A
11	47354445	rs730880674A	AAGT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880674A
11	47354445	rs730880674A	AAGT	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880674A
11	47354753	rs730880672TC	T	TC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880672TC
11	47354857	rs730880668CG	C	CG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880668CG
11	47355219	rs730880666TT	C	TT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880666TT
11	47372844	rs730880664C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880664C
11	47372899	rs730880663G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880663G
11	47372909	rs730880662G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880662G
11	47356758	rs730880660A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880660A
11	47357445	rs730880657T	TCCACGCTGTAG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880657T
11	47357554	rs397515979T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515979T
11	47357560	rs730880655G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880655G
11	47359005	rs730880654A	AGACGCGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880654A
11	47359032	rs730880653C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880653C
11	47359032	rs730880653C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880653C
11	47359084	rs730880652C	CCGCAT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880652C
11	47359084	rs730880652C	CCGCAT	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880652C
11	47360111	rs730880651A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880651A
11	47360111	rs730880651A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880651A
11	47362747	rs730880649GT	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880649GT
11	47362793	rs730880647A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880647A
11	47363597	rs730880646T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880646T
11	47363630	rs727503197C	CCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503197C
11	47365041	rs730880641C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880641C
11	47364157	rs730880640G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880640G
11	47365042	rs730880639T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880639T
11	47365065	rs730880637A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880637A
11	47365146	rs730880635A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880635A
11	47365146	rs730880635A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880635A
11	47365146	rs730880635A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880635A
11	47367833	rs730880631A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880631A
11	47368981	rs730880629A	T	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880629A
11	47368981	rs730880629A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880629A
11	47369031	rs368121566T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs368121566T
11	47371426	rs375607980A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375607980A
11	47371426	rs375607980A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375607980A
11	47371564	rs730880620T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880620T
11	47371586	rs730880618A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880618A
11	47371586	rs730880618A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880618A
11	47353662	rs730880605A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880605A
11	47353664	rs730880604C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880604C
11	47353666	rs730880603T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880603T
11	47353686	rs730880601G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880601G
11	47353705	rs730880600T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880600T
11	47353705	rs730880600T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880600T
11	47353773	rs730880598A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880598A
11	47353796	rs730880597T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880597T
11	47354256	rs730880592C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880592C
11	47354256	rs730880592C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880592C
11	47354364	rs397516020A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516020A
11	47354364	rs397516020A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516020A
11	47354743	rs387906397G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs387906397G
11	47355264	rs730880586A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880586A
11	47355264	rs730880586A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880586A
11	47355304	rs730880584T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880584T
11	47355475	rs11570112A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs11570112A
11	47356605	rs730880578A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880578A
11	47356605	rs730880578A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880578A
11	47356750	rs730880576T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880576T
11	47359085	rs2856655G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2856655G
11	47359273	rs730880565A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880565A
11	47359273	rs730880565A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880565A
11	47362584	rs730880558T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880558T
11	47362755	rs730880555T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880555T
11	47363601	rs730880546T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880546T
11	47364231	rs730880544A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880544A
11	47364231	rs730880544A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880544A
11	47364381	rs730880542T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880542T
11	47364451	rs730880538A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880538A
11	47364671	rs730880533A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880533A
11	47364698	rs730880531C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880531C
15	35085622	rs730880388T	TAGA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GJD2-DT,ACTC1;VARIANT_ID=rs730880388T
2	179444429	rs574660186A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126806423,TTN,TTN-AS1;VARIANT_ID=rs574660186A
1	201331117	rs45586240A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs45586240A
3	46900999	rs730880162T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs730880162T
14	23896793	rs113186231T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs113186231T
14	23884630	rs200303340T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs200303340T
14	23886382	rs121913647T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs121913647T
14	23893253	rs730880161T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880161T
14	23897055	rs730880160T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880160T
14	23898240	rs730880159G	T	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880159G
11	47365176	rs730880143T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880143T
11	47354848	rs730880140C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880140C
11	47355559	rs730880138A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880138A
14	23887513	rs45451303T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45451303T
14	23888450	rs727505325T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727505325T
14	23900668	rs727505202G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727505202G
14	23900668	rs727505202G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727505202G
11	47364592	rs727505152C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727505152C
2	179429538	rs557312035C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs557312035C
11	47371603	rs730880366AG	A	AG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880366AG
11	47372866	rs730880362GCC	G	GCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880362GCC
19	55663260	rs104894729G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894729G
11	47353792	rs730880361GA	G	GA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880361GA
19	55667646	rs727504872G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504872G
11	47359263	rs727504864T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504864T
2	179477885	rs727504851T	TA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs727504851T
19	55665439	rs727503504A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503504A
14	23898554	rs727504753T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504753T
14	23887432	rs727504703A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504703A
11	47369407	rs397516073G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516073G
X	119590559	rs730880344CAT	C	CAT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs730880344CAT
11	47355514	rs727504423A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504423A
14	23900206	rs727504409C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504409C
14	23893346	rs727504407C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504407C
15	35086934	rs727504399T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs727504399T
7	151269771	rs727504392A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs727504392A
11	47353745	rs727504390C	CTG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504390C
14	23884419	rs727504385C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504385C
11	47357560	rs727504371T	GA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504371T
14	23900998	rs397516260A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516260A
11	47363653	rs727504366T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504366T
11	47363653	rs727504366T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504366T
11	47359259	rs730880341CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880341CA
11	47359259	rs730880341CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880341CA
1	201328765	rs376923877T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs376923877T
11	47359003	rs397515974T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515974T
11	47367848	rs573916965A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs573916965A
11	47367848	rs573916965A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs573916965A
11	47367848	rs573916965A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs573916965A
3	46900980	rs199474707A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs199474707A
11	47355107	rs111683277T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111683277T
11	47355107	rs111683277T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111683277T
11	47356751	rs727504349T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504349T
X	100652970	rs727504348T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs727504348T
19	55663260	rs104894729A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894729A
11	47353684	rs397516039C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516039C
11	47360231	rs727504334T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504334T
11	47360231	rs727504334T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504334T
11	47355563	rs727504333C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504333C
1	201334370	rs727504331C	A	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504331C
1	201334370	rs727504331C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504331C
1	201334370	rs727504331C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504331C
11	47365056	rs727504329A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504329A
14	23887443	rs727504325T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504325T
14	23887443	rs727504325T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504325T
15	35084306	rs727504323C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs727504323C
11	47354377	rs727504321T	TAA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504321T
11	47357427	rs727504314G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504314G
14	23893979	rs727503254A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727503254A
14	23894114	rs727504311C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504311C
14	23894114	rs727504311C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs727504311C
15	35085517	rs727504308A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs727504308A
11	47354525	rs727504305T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504305T
14	23895206	rs727504272T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504272T
11	47354519	rs730880337CCACT	C	CCACT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880337CCACT
11	47367849	rs367947846C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs367947846C
11	47362557	rs727504293A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504293A
11	47354483	rs727504289T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504289T
11	47354483	rs727504289T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504289T
11	47364237	rs727504287C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504287C
11	47364237	rs727504287C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504287C
11	47364237	rs727504287C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504287C
11	47367805	rs730880336ATGCCG	A	ATGCCG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880336ATGCCG
19	55663243	rs727504285C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504285C
19	55663243	rs727504285C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504285C
19	55663243	rs727504285C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504285C
14	23901013	rs727504283A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504283A
11	47367757	rs727504269A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504269A
11	47364580	rs727504279G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504279G
1	201334411	rs727504277T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504277T
11	47354520	rs727504276T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504276T
19	55663224	rs727504275T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504275T
19	55663224	rs727504275T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504275T
11	47372125	rs730880335CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs730880335CA
11	47354134	rs727504271C	CAGCACAGCAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504271C
11	47367757	rs727504269T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504269T
11	47367757	rs727504269T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504269T
14	23901713	rs727504267C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727504267C
11	47356716	rs727504265A	ATG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504265A
15	63353134	rs727504264C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs727504264C
1	201334758	rs727504255T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504255T
1	201334758	rs727504255T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504255T
11	47359107	rs727504252A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504252A
11	47363703	rs727504248C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504248C
1	201328345	rs727504247T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504247T
1	201328345	rs727504247T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504247T
1	201328345	rs727504247T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504247T
1	201328372	rs397516484G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516484G
1	201328372	rs397516484G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516484G
1	201332458	rs727504246A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504246A
1	201332458	rs727504246A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504246A
1	201334389	rs727504245A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727504245A
19	55663225	rs727504243A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504243A
19	55665450	rs727504242A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504242A
19	55665450	rs727504242A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727504242A
11	47355293	rs727504235T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727504235T
2	179397250	rs727504184A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs727504184A
2	179468776	rs727503602T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN-AS1,TTN;VARIANT_ID=rs727503602T
2	179412173	rs727503547CTGCTAGA	G	CTGCTAGA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs727503547CTGCTAGA
1	201334420	rs727503513A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727503513A
1	201334420	rs727503513A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727503513A
1	201332477	rs727503512C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs727503512C
1	201331116	rs121964860T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964860T
1	201328750	rs111377893A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs111377893A
1	201328750	rs111377893A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs111377893A
19	55667592	rs727503507C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503507C
19	55666111	rs727503506G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503506G
19	55665439	rs727503504C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503504C
19	55665438	rs727503503T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503503T
19	55665421	rs727503501T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503501T
19	55663267	rs727503500A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503500A
19	55663261	rs727503499A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503499A
19	55663261	rs727503499A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs727503499A
12	111348900	rs727503296C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs727503296C
14	23899110	rs727503271T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503271T
14	23899016	rs397516089G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516089G
14	23898538	rs727503269C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503269C
14	23896061	rs727503264G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503264G
14	23894144	rs397516153T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516153T
14	23894085	rs2754158C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs2754158C
14	23893328	rs727503253A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503253A
14	23893328	rs727503253A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503253A
14	23888797	rs727503249A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503249A
14	23887464	rs727503245C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503245C
14	23887464	rs727503245C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs727503245C
14	23886383	rs45544633A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs45544633A
14	23886383	rs45544633A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs45544633A
11	47372116	rs727503220A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503220A
11	47371560	rs727503219G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503219G
11	47371445	rs727503217C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503217C
11	47369219	rs727503212T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503212T
11	47369219	rs727503212T	TC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503212T
11	47367882	rs727503211T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503211T
11	47367869	rs727503210A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503210A
11	47367854	rs727503209CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503209CA
11	47364571	rs727503204T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503204T
11	47364571	rs727503204T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503204T
11	47364571	rs727503204T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503204T
11	47364479	rs727503203A	AGG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503203A
11	47364479	rs727503203A	AGG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503203A
11	47364376	rs727503202G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503202G
11	47364376	rs727503202G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503202G
11	47364270	rs397515905A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515905A
11	47364270	rs397515905A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515905A
11	47364270	rs397515905A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515905A
11	47364269	rs200411226T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs200411226T
11	47364269	rs200411226T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs200411226T
11	47364269	rs200411226T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs200411226T
11	47364162	rs397515912T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515912T
11	47364162	rs397515912T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515912T
11	47364162	rs397515912T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515912T
11	47364127	rs111437311G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111437311G
11	47364127	rs111437311G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111437311G
11	47363542	rs727503195T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503195T
11	47363542	rs727503195T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503195T
11	47362745	rs727503194C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503194C
11	47362717	rs397515932T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515932T
11	47361269	rs727503192C	AG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503192C
11	47361269	rs727503192C	AG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503192C
11	47359095	rs727503188A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503188A
11	47359095	rs727503188A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503188A
11	47359005	rs727503187A	AGACGCGCATCTCGTACACCACG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503187A
11	47358987	rs727503186C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503186C
11	47357426	rs727503184T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503184T
11	47356621	rs727503182C	CGT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503182C
11	47355547	rs727503180A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503180A
11	47355547	rs727503180A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503180A
11	47355502	rs727503178A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503178A
11	47355471	rs727503176G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503176G
11	47355215	rs397516002A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516002A
11	47355196	rs727503175G	GGCCCGGATGAACA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503175G
11	47355169	rs573821685T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs573821685T
11	47355131	rs727503174GC	G	GC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503174GC
11	47354786	rs727503172G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503172G
11	47354786	rs727503172G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503172G
11	47354786	rs727503172G	GC	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503172G
11	47354131	rs727503171A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503171A
11	47353674	rs727503167T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503167T
11	47353660	rs727503166C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503166C
11	47353660	rs727503166C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503166C
X	119590505	rs727503120T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs727503120T
X	119576505	rs727503118A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs727503118A
1	236882307	rs727502886A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 23 WITH OR WITHOUT VENTRICULAR NONCOMPACTION;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTN2;VARIANT_ID=rs727502886A
1	236882307	rs727502886A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTN2;VARIANT_ID=rs727502886A
1	236882307	rs727502886A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTN2;VARIANT_ID=rs727502886A
11	47353795	rs368765949T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs368765949T
11	47353795	rs368765949T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs368765949T
19	55665463	rs368861241A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs368861241A
19	55665463	rs368861241A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs368861241A
11	47359343	rs371488302T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs371488302T
12	111352025	rs587782965T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs587782965T
12	111352025	rs587782965T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs587782965T
12	111352025	rs587782965T	G	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs587782965T
14	23891476	rs587782962T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs587782962T
14	23891476	rs587782962T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs587782962T
11	47355103	rs587782958T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587782958T
11	47355103	rs587782958T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587782958T
11	47355103	rs587782958T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587782958T
11	47364243	rs587782957T	TGAACC	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587782957T
20	42788945	rs587782951T	G	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=JPH2;VARIANT_ID=rs587782951T
20	42788945	rs587782951T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=JPH2;VARIANT_ID=rs587782951T
14	23885229	rs587779393G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs587779393G
14	23885331	rs587779392G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs587779392G
11	47364832	rs587776699T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587776699T
11	47364832	rs587776699T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587776699T
12	111348898	rs199474814T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs199474814T
12	111348898	rs199474814T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs199474814T
1	201333455	rs483352832A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs483352832A
14	23897714	rs606231324T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs606231324T
14	23897714	rs606231324T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs606231324T
14	23893352	rs606231340T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs606231340T
2	179410768	rs753334568A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs753334568A
2	179410829	rs869320740G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs869320740G
1	201333485	rs45525839A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs45525839A
11	47357423	rs398123280T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs398123280T
11	47363689	rs398123279T	TAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs398123279T
11	47363689	rs398123279T	TAC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs398123279T
11	47363689	rs398123279T	TAC	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs398123279T
6	74190500	rs398122419T	C	T	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs398122419T
6	74191932	rs201544686A	G	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs201544686A
7	128486450	rs138193236T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs138193236T
7	150648619	rs199472948T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=KCNH2;VARIANT_ID=rs199472948T
1	156107442	rs267607581G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LMNA;VARIANT_ID=rs267607581G
2	220290456	rs267607490T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=DES;VARIANT_ID=rs267607490T
2	224824538	rs143697995G	T	G	.	PASS	PHENOTYPE=INFANTILE HYPERTROPHIC CARDIOMYOPATHY DUE TO MRPL44 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MRPL44;VARIANT_ID=rs143697995G
11	47364284	rs397514752A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397514752A
1	156105731	rs56851164A	T	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LMNA;VARIANT_ID=rs56851164A
2	179424036	rs397517735T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs397517735T
2	179439257	rs397517689A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs397517689A
2	179454576	rs72646846A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs72646846A
7	151272015	rs397517283T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs397517283T
10	88477867	rs145983824T	C	T	.	PASS	PHENOTYPE=FAMILIAL HYPERTROPHIC CARDIOMYOPATHY 24;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LDB3;VARIANT_ID=rs145983824T
15	35084464	rs397517067T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs397517067T
17	37822330	rs397516863A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs397516863A
17	37822330	rs397516863A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs397516863A
17	37822330	rs397516863A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs397516863A
11	19207891	rs397516855G	GGGACCTGTT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs397516855G
6	118880119	rs397516784T	TAAG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 18;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CEP85L,PLN;VARIANT_ID=rs397516784T
X	119576518	rs397516752G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs397516752G
X	119580153	rs397516751T	TACTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs397516751T
X	119589391	rs397516739GT	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs397516739GT
X	119589417	rs397516738T	TA	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs397516738T
X	119590506	rs397516736C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs397516736C
X	119590506	rs397516736T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs397516736T
1	236911044	rs200248944T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 23 WITH OR WITHOUT VENTRICULAR NONCOMPACTION;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTN2;VARIANT_ID=rs200248944T
1	201328348	rs141121678T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs141121678T
1	201328349	rs367785431A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs367785431A
1	201328750	rs111377893T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs111377893T
1	201328750	rs111377893T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs111377893T
1	201330414	rs397516482A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516482A
1	201330414	rs397516482A	T	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516482A
1	201331098	rs45578238A	ATCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs45578238A
1	201332476	rs397516471T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516471T
1	201332504	rs397516470T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516470T
1	201332504	rs397516470T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516470T
1	201332518	rs45501500T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs45501500T
1	201333469	rs397516466T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516466T
1	201333485	rs45525839C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs45525839C
1	201333493	rs397516464G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516464G
1	201333493	rs397516464T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516464T
1	201333497	rs397516463A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516463A
1	201333497	rs397516463A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516463A
1	201334409	rs397516459A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516459A
1	201334409	rs397516459A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516459A
1	201334419	rs397516457A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516457A
1	201334419	rs397516457A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516457A
1	201334419	rs397516457T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516457T
1	201334419	rs397516457T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516457T
1	201334426	rs397516456A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516456A
1	201334426	rs397516456A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516456A
1	201334426	rs397516456A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516456A
1	201334745	rs397516455G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516455G
1	201334745	rs397516455G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516455G
1	201334751	rs397516452G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs397516452G
12	111356921	rs397516408C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC114827850,MYL2;VARIANT_ID=rs397516408C
12	111356921	rs397516408C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC114827850,MYL2;VARIANT_ID=rs397516408C
12	111348894	rs397516407G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs397516407G
12	111348894	rs397516407G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs397516407G
12	111348897	rs397516406T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs397516406T
12	111350901	rs143139258G	T	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs143139258G
12	111352004	rs397516399G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs397516399G
12	111352071	rs397516398T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs397516398T
15	63335092	rs397516382A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs397516382A
15	63335092	rs397516382A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs397516382A
15	63351862	rs397516373A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs397516373A
15	63351862	rs397516373A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs397516373A
19	55663278	rs397516357T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516357T
19	55663278	rs397516357T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516357T
19	55663278	rs397516357T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516357T
19	55665403	rs397516355T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516355T
19	55665462	rs397516354G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516354G
19	55665462	rs397516354G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516354G
19	55665462	rs397516354T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516354T
19	55665462	rs397516354T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516354T
19	55665462	rs397516354T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516354T
19	55665477	rs397516353A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516353A
19	55665477	rs397516353A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516353A
19	55665477	rs397516353A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516353A
19	55665412	rs397516351C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516351C
19	55665513	rs397516349T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516349T
19	55665513	rs397516349T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516349T
19	55665513	rs397516349T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516349T
19	55665516	rs121917760G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs121917760G
19	55665525	rs397516347T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516347T
19	55665525	rs397516347T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516347T
19	55668677	rs397516340A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs397516340A
3	46901000	rs202141423G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 8;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs202141423G
14	23900133	rs397516272A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516272A
14	23900133	rs397516272A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516272A
14	23900161	rs397516271A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516271A
14	23900792	rs397516266A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516266A
14	23900792	rs397516266A	AC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516266A
14	23900811	rs397516264T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516264T
14	23900811	rs397516264T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516264T
14	23900811	rs397516264T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516264T
14	23900816	rs397516263T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516263T
14	23900817	rs45516091A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45516091A
14	23900817	rs45516091A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45516091A
14	23901007	rs397516258G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516258G
14	23882996	rs397516256T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516256T
14	23883018	rs397516254T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516254T
14	23883283	rs45520836T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45520836T
14	23884362	rs397516248T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516248T
14	23901711	rs397516238A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516238A
14	23886196	rs397516220T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516220T
14	23886789	rs397516208T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs397516208T
14	23889202	rs397516187T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516187T
14	23889202	rs397516187T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516187T
14	23891500	rs397516178A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516178A
14	23891500	rs397516178A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516178A
14	23893244	rs397516172T	TCTC	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516172T
14	23893294	rs397516166G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516166G
14	23893294	rs397516166G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516166G
14	23893327	rs397516165T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516165T
14	23894115	rs397516155C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516155C
14	23894115	rs397516155C	CCTT	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516155C
14	23894115	rs397516155C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516155C
14	23894132	rs397516154T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516154T
14	23894144	rs397516153A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516153A
14	23894566	rs397516142G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516142G
14	23894566	rs397516142G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs397516142G
14	23895022	rs397516135T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516135T
14	23895212	rs397516134G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516134G
14	23895230	rs397516132T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516132T
14	23899016	rs397516089T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516089T
14	23899109	rs397516087G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs397516087G
11	47367793	rs1555122751A	AGCCTCTTTAGCATGCCGCGCAGGTCAGTGACGCCGTACTGGAAGGCGATGCGCTCGTACTCAGATGGGGGT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs1555122751A
11	47367930	rs397516083T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516083T
11	47367930	rs397516083T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516083T
11	47367930	rs397516083T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516083T
11	47367923	rs397516082C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516082C
11	47367923	rs397516082C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516082C
11	47367923	rs397516082C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516082C
11	47367931	rs201078659T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs201078659T
11	47368189	rs397516080G	GAA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516080G
11	47368189	rs397516080G	GAA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516080G
11	47368189	rs397516080G	GAA	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516080G
11	47369403	rs397516077T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516077T
11	47369403	rs397516077T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516077T
11	47369406	rs397516076G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516076G
11	47369975	rs397516074T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516074T
11	47369975	rs397516074T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516074T
11	47369975	rs397516074T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516074T
11	47369407	rs397516073T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516073T
11	47369407	rs397516073T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516073T
11	47369407	rs397516073T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516073T
11	47369974	rs397516072T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516072T
11	47369974	rs397516072T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516072T
11	47370037	rs397516070G	T	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516070G
11	47370037	rs397516070G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516070G
11	47370037	rs397516070G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516070G
11	47370092	rs397516068G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516068G
11	47370092	rs397516068G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516068G
11	47370092	rs397516068G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516068G
11	47370093	rs397516067T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516067T
11	47371343	rs397516062C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516062C
11	47371366	rs397516061A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516061A
11	47371366	rs397516061A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516061A
11	47371427	rs397516059CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516059CA
11	47371427	rs397516059CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516059CA
11	47371418	rs397516058A	AGGCGGCTTCAGGAGGCTGGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516058A
11	47371475	rs397516057G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516057G
11	47371474	rs397516056A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516056A
11	47371589	rs397516053T	G	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516053T
11	47371610	rs397516052T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516052T
11	47371610	rs397516052T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516052T
11	47371628	rs397516050T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516050T
11	47371633	rs397516049GT	G	GT	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516049GT
11	47371633	rs397516049GT	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516049GT
11	47371637	rs397516047G	GAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516047G
11	47371637	rs397516047G	GAC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516047G
11	47353433	rs397516044T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516044T
11	47353433	rs397516044T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516044T
11	47353433	rs397516044T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516044T
11	47353626	rs397516042A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516042A
11	47353626	rs397516042A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516042A
11	47353626	rs397516042A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516042A
11	47353667	rs397516040T	TTGG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516040T
11	47353667	rs397516040T	TTGG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516040T
11	47353701	rs397516038A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516038A
11	47353701	rs397516038A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516038A
11	47353740	rs397516037A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516037A
11	47353740	rs397516037A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516037A
11	47353740	rs397516037A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516037A
11	47353743	rs397516035A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516035A
11	47353743	rs397516035A	T	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516035A
11	47372096	rs397516032C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516032C
11	47354116	rs397516031T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516031T
11	47354116	rs397516031T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516031T
11	47354119	rs397516029T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516029T
11	47354119	rs397516029T	TG	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516029T
11	47354119	rs397516029T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516029T
11	47354119	rs397516029TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516029TG
11	47354119	rs397516029TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516029TG
11	47354145	rs397516028G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516028G
11	47372108	rs397516023A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516023A
11	47354255	rs397516022A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516022A
11	47354255	rs397516022A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516022A
11	47354364	rs397516020T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516020T
11	47354364	rs397516020T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516020T
11	47354375	rs397516019GATAA	G	GATAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516019GATAA
11	47354442	rs187705120G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs187705120G
11	47354740	rs373746463A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373746463A
11	47354740	rs373746463G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373746463G
11	47354740	rs373746463G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373746463G
11	47354740	rs373746463G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373746463G
11	47354777	rs397516014AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516014AC
11	47354782	rs397516013T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516013T
11	47354782	rs397516013T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516013T
11	47354822	rs397516010A	C	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516010A
11	47354822	rs397516010A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516010A
11	47354848	rs397516008TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516008TA
11	47354848	rs397516008TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516008TA
11	47354848	rs397516008TA	T	TA	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516008TA
11	47354882	rs397516007TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516007TG
11	47354842	rs397516006T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516006T
11	47354842	rs397516006T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516006T
11	47355106	rs113358486C	A	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113358486C
11	47355106	rs113358486C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113358486C
11	47355106	rs113358486C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs113358486C
11	47355117	rs397516005A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516005A
11	47355117	rs397516005A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516005A
11	47355117	rs397516005A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516005A
11	47355229	rs397516001GT	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397516001GT
11	47355257	rs397515997A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515997A
11	47355257	rs397515997A	AG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515997A
11	47355519	rs397515995A	ATGGTC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515995A
11	47356593	rs397515992A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515992A
11	47356593	rs397515992A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515992A
11	47356593	rs397515992A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515992A
11	47356592	rs397515991G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515991G
11	47356592	rs397515991T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515991T
11	47356592	rs397515991T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515991T
11	47356632	rs397515990C	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515990C
11	47356632	rs397515990C	CAG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515990C
11	47356632	rs397515990C	CAG	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515990C
11	47356663	rs397515987C	CCG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515987C
11	47356663	rs397515987C	CCG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515987C
11	47357495	rs397515982T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515982T
11	47357495	rs397515982T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515982T
11	47357495	rs397515982T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515982T
11	47357554	rs397515979TG	T	TG	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515979TG
11	47373058	rs376395543C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs376395543C
11	47373058	rs376395543C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs376395543C
11	47358985	rs397515977G	GC	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515977G
11	47358987	rs397515975AGA	CG	AGA	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515975AGA
11	47358987	rs397515975AGA	CG	AGA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515975AGA
11	47359003	rs397515974C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515974C
11	47359003	rs397515974C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515974C
11	47359005	rs397515973A	AGACGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515973A
11	47359005	rs397515973A	AGACGC	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515973A
11	47359007	rs397515972A	ACGCGCATCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515972A
11	47359019	rs397515970TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515970TA
11	47359019	rs397515970TA	T	TA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515970TA
11	47359053	rs397515966GA	G	GA	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515966GA
11	47359053	rs397515966GA	G	GA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515966GA
11	47359053	rs397515966GA	G	GA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515966GA
11	47359090	rs397515965T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515965T
11	47359090	rs397515965T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515965T
11	47359115	rs375675796T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375675796T
11	47359115	rs375675796T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375675796T
11	47359280	rs397515963AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515963AC
11	47359280	rs397515963AC	A	AC	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515963AC
11	47359280	rs397515963AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515963AC
11	47359342	rs397515960AC	A	AC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515960AC
11	47359342	rs397515960AC	A	AC	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515960AC
11	47359347	rs111729952C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111729952C
11	47359347	rs111729952C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111729952C
11	47359347	rs111729952C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs111729952C
11	47360070	rs112738974A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs112738974A
11	47360070	rs112738974T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs112738974T
11	47360070	rs112738974T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs112738974T
11	47360070	rs112738974T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs112738974T
11	47360070	rs112738974T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs112738974T
11	47360197	rs397515954A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515954A
11	47360215	rs397515952C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515952C
11	47360909	rs397515948GT	G	GT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515948GT
11	47360926	rs397515947T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515947T
11	47360926	rs397515947T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515947T
11	47372876	rs397515945T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515945T
11	47361228	rs397515944CA	C	CA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515944CA
11	47361253	rs397515943CC	AGGG	CC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515943CC
11	47361253	rs397515943CC	AGGG	CC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515943CC
11	47361221	rs397515942T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515942T
11	47361335	rs397515938A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515938A
11	47361343	rs397515937C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515937C
11	47361343	rs397515937C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515937C
11	47361343	rs397515937C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515937C
11	47362688	rs397515935T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515935T
11	47362690	rs397515934C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515934C
11	47362693	rs397515933G	GA	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515933G
11	47362722	rs397515931C	CG	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515931C
11	47362785	rs397515926G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515926G
11	47362785	rs397515926G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515926G
11	47363546	rs199728019T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs199728019T
11	47372894	rs397515925C	CGTGTGCCCTCT	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515925C
11	47372894	rs397515925C	CGTGTGCCCTCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515925C
11	47372894	rs397515925C	CGTGTGCCCTCT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515925C
11	47363639	rs397515920A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515920A
11	47364125	rs397515916A	T	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515916A
11	47364125	rs397515916A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515916A
11	47364125	rs397515916A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515916A
11	47364162	rs397515912G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515912G
11	47364162	rs397515912G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515912G
11	47364162	rs397515912G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515912G
11	47364178	rs397515910C	A	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515910C
11	47364178	rs397515910C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515910C
11	47364248	rs397515907T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515907T
11	47364248	rs397515907T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515907T
11	47364248	rs397515907T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515907T
11	47364249	rs375882485A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375882485A
11	47364249	rs375882485A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375882485A
11	47364249	rs375882485A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs375882485A
11	47364270	rs397515905C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515905C
11	47364270	rs397515905C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515905C
11	47364270	rs397515905C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515905C
11	47364296	rs397515903T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515903T
11	47364570	rs397515897G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515897G
11	47364570	rs397515897G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515897G
11	47364612	rs397515896C	CA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515896C
11	47364650	rs397515895A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515895A
11	47364686	rs397515894C	CAA	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515894C
11	47364709	rs397515893T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515893T
11	47364709	rs397515893T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515893T
11	47364709	rs397515893T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515893T
11	47364815	rs397515891C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515891C
11	47365097	rs397515889T	TG	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515889T
11	47365097	rs397515889T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515889T
11	47365097	rs397515889T	TG	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515889T
11	47365110	rs397515888A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515888A
11	47367809	rs397515884T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs397515884T
14	23884684	rs367543052A	ATCT	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MHRT,MYH7;VARIANT_ID=rs367543052A
3	12645688	rs121434594C	G	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=RAF1;VARIANT_ID=rs121434594C
3	12645700	rs727505017G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=RAF1;VARIANT_ID=rs727505017G
12	112891083	rs397507520C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PTPN11;VARIANT_ID=rs397507520C
3	52486233	rs397514616A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 13;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs397514616A
2	179391825	rs281864930G	GT	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs281864930G
11	47356671	rs387907267A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs387907267A
11	47356671	rs387907267A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs387907267A
7	151273524	rs193922697T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs193922697T
11	47367916	rs193922386T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922386T
11	47367916	rs193922386T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922386T
11	47367916	rs193922386T	G	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922386T
11	47354447	rs193922383T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922383T
11	47359280	rs187830361G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs187830361G
11	47359280	rs187830361G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs187830361G
11	47359280	rs187830361G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs187830361G
11	47360071	rs36211723T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs36211723T
11	47360071	rs36211723T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs36211723T
11	47360071	rs36211723T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs36211723T
X	119582917	rs193922649C	CT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs193922649C
11	19207812	rs193922667T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs193922667T
15	35086943	rs193922681G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs193922681G
6	74191784	rs143747297A	G	A	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs143747297A
6	74207559	rs397518449CA	C	CA	.	PASS	PHENOTYPE=MITOCHONDRIAL HYPERTROPHIC CARDIOMYOPATHY WITH LACTIC ACIDOSIS DUE TO MTO1 DEFICIENCY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MTO1;VARIANT_ID=rs397518449CA
15	63351866	rs199476311A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476311A
15	63335073	rs199476301T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476301T
15	63349218	rs199476310C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476310C
15	63356332	rs199476321C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476321C
15	63356332	rs199476321C	T	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476321C
15	63354462	rs199476317A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476317A
15	63354462	rs199476317A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476317A
15	63354418	rs199476316T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476316T
15	63354418	rs199476316T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476316T
15	63353922	rs199476315A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476315A
15	63353922	rs199476315A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476315A
15	63353922	rs199476315A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476315A
15	63353114	rs104894502T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894502T
15	63336299	rs199476306T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476306T
15	63336299	rs199476306T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476306T
15	63336295	rs199476305C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs199476305C
10	69881254	rs140148105G	A	G	.	PASS	PHENOTYPE=FAMILIAL HYPERTROPHIC CARDIOMYOPATHY 22;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYPN;VARIANT_ID=rs140148105G
10	69959174	rs71534278T	C	T	.	PASS	PHENOTYPE=FAMILIAL HYPERTROPHIC CARDIOMYOPATHY 22;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYPN;VARIANT_ID=rs71534278T
3	46900983	rs199474706C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 8;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs199474706C
3	46902192	rs199474703T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs199474703T
3	46902192	rs199474703T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 8;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs199474703T
3	46902192	rs199474703T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs199474703T
12	111348885	rs199474815A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs199474815A
12	111348980	rs199474813G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs199474813G
3	8775678	rs116840787C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CAV3;VARIANT_ID=rs116840787C
1	78383902	rs387907079G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 20;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126805765,NEXN;VARIANT_ID=rs387907079G
4	120107298	rs140126678G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 16;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYOZ2;VARIANT_ID=rs140126678G
4	120072092	rs199476398C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 16;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYOZ2;VARIANT_ID=rs199476398C
20	42788933	rs387906898A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 17;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=JPH2;VARIANT_ID=rs387906898A
20	42789006	rs387906897G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 17;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=JPH2;VARIANT_ID=rs387906897G
20	42815045	rs1600482909G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 17;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=JPH2;VARIANT_ID=rs1600482909G
11	47360145	rs727503190C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs727503190C
6	118869382	rs920627366G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 18;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CEP85L,PLN;VARIANT_ID=rs920627366G
7	128475604	rs387906587A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC;VARIANT_ID=rs387906587A
15	35085599	rs193922680T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GJD2-DT,ACTC1;VARIANT_ID=rs193922680T
15	35085599	rs193922680T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GJD2-DT,ACTC1;VARIANT_ID=rs193922680T
15	35084729	rs267606628C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs267606628C
15	35082750	rs267606629G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs267606629G
15	35083416	rs121912675A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GJD2-DT,ACTC1;VARIANT_ID=rs121912675A
15	35083364	rs121912673T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 11;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ACTC1,GJD2-DT;VARIANT_ID=rs121912673T
7	128498529	rs121909518A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 26;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=FLNC,FLNC-AS1;VARIANT_ID=rs121909518A
4	186066174	rs121912683A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=SLC25A4;VARIANT_ID=rs121912683A
14	23884467	rs267606909T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861897,MYH7;VARIANT_ID=rs267606909T
14	23900793	rs730880850T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880850T
14	23900793	rs730880850T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs730880850T
14	23884385	rs121913654G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913654G
14	23884385	rs121913654G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913654G
14	23886382	rs121913647G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MHRT,MYH7;VARIANT_ID=rs121913647G
14	23884230	rs28933098A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs28933098A
14	23894622	rs121913643C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC126861898,MYH7;VARIANT_ID=rs121913643C
14	23897088	rs121913642G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs121913642G
14	None	VCV000014096	None	None	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=VCV000014096
12	111356949	rs104894370G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2,LOC114827850;VARIANT_ID=rs104894370G
12	111356949	rs104894370G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2,LOC114827850;VARIANT_ID=rs104894370G
12	111352091	rs104894369T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs104894369T
12	111352091	rs104894369T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs104894369T
12	111352091	rs104894369T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs104894369T
12	111351120	rs121913658C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL2;VARIANT_ID=rs121913658C
12	111356937	rs104894368T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 10;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC114827850,MYL2;VARIANT_ID=rs104894368T
12	111356937	rs104894368T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LOC114827850,MYL2;VARIANT_ID=rs104894368T
3	46901019	rs104893750T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs104893750T
3	46901019	rs104893750T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs104893750T
3	46901001	rs104893748C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 8;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs104893748C
3	46901001	rs104893748C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYL3;VARIANT_ID=rs104893748C
3	12626123	rs80338797C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=RAF1;VARIANT_ID=rs80338797C
3	12645688	rs121434594A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=RAF1;VARIANT_ID=rs121434594A
6	118880200	rs111033560G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 18;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PLN,CEP85L;VARIANT_ID=rs111033560G
6	118880200	rs111033560G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PLN,CEP85L;VARIANT_ID=rs111033560G
15	89868870	rs113994096A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=POLG;VARIANT_ID=rs113994096A
15	89873415	rs11394094 rs113994094A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=POLG;VARIANT_ID=rs11394094 rs113994094A
12	112926270	rs121918457T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PTPN11;VARIANT_ID=rs121918457T
2	179391925	rs281864927TTTTTCTTTCA	CCATGTTACTT	TTTTTCTTTCA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN,TTN-AS1;VARIANT_ID=rs281864927TTTTTCTTTCA
2	179650726	rs28933405A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TTN;VARIANT_ID=rs28933405A
15	63349227	rs104894504C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894504C
15	63349227	rs104894504C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894504C
15	63353098	rs104894503A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894503A
15	63353098	rs104894503A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894503A
15	63353098	rs104894503A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894503A
15	63353114	rs104894502G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 3;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894502G
15	63353114	rs104894502G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TPM1;VARIANT_ID=rs104894502G
3	52488009	rs267607125A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs267607125A
3	52488009	rs267607125A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 13;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNC1;VARIANT_ID=rs267607125A
19	55668465	rs267607128A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs267607128A
19	55668465	rs267607128A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs267607128A
19	55665397	rs2147283135C	CCTT	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs2147283135C
19	55663228	rs267607127T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs267607127T
19	55665436	rs121917761T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs121917761T
19	55665514	rs104894724A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894724A
19	55665514	rs104894724A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894724A
19	55665415	rs104894730C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894730C
19	55663260	rs104894729T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894729T
19	55663260	rs104894729T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894729T
19	55663266	rs104894728C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894728C
19	55663249	rs104894727T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894727T
19	55663249	rs104894727T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894727T
19	55663219	rs104894725G	T	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894725G
19	55665514	rs104894724C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 7;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894724C
19	55665514	rs104894724C	G	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNI3;VARIANT_ID=rs104894724C
1	201333494	rs74315380A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs74315380A
1	201333464	rs74315379A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs74315379A
1	201333464	rs74315379A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs74315379A
1	201334372	rs121964858T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964858T
1	201334372	rs121964858T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964858T
1	201328373	rs121964857A	G	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964857A
1	201334425	rs121964856T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964856T
1	201334425	rs121964856T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964856T
1	201334766	rs121964855T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964855T
1	201334766	rs121964855T	A	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TNNT2;VARIANT_ID=rs121964855T
X	100654735	rs199473684T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs199473684T
X	100656740	rs104894845T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs104894845T
X	100653930	rs28935197C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs28935197C
X	100653455	rs104894828T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GLA,RPL36A-HNRNPH2;VARIANT_ID=rs104894828T
X	119576454	rs104894858T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LAMP2;VARIANT_ID=rs104894858T
MT	9997	rs121434475C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MT-TG;VARIANT_ID=rs121434475C
MT	4300	rs121434470G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MT-TI;VARIANT_ID=rs121434470G
MT	4295	rs121434467G	A	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MT-TI;VARIANT_ID=rs121434467G
7	6045549	rs121434629A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 9;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PMS2;VARIANT_ID=rs121434629A
11	19209800	rs281865416CCCCT	TCCGA	CCCCT	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs281865416CCCCT
11	19209833	rs104894205G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs104894205G
11	19209792	rs104894204C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 12;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CSRP3;VARIANT_ID=rs104894204C
11	47354743	rs387906397C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs387906397C
11	47354743	rs387906397C	A	C	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs387906397C
11	47354743	rs387906397C	A	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs387906397C
11	47368581	rs587776700G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587776700G
11	47368581	rs587776700G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs587776700G
11	47359085	rs2856655T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2856655T
11	47359085	rs2856655T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2856655T
11	47359085	rs2856655T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs2856655T
11	47354789	rs121909377A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909377A
11	47354789	rs121909377A	C	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909377A
11	47372907	rs121909375C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909375C
11	47353775	rs886041031GCCATTCTTGAA	AGGT	GCCATTCTTGAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886041031GCCATTCTTGAA
11	47359371	rs886041030C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs886041030C
11	47364129	rs121909374G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909374G
11	47364129	rs121909374G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909374G
11	47364129	rs121909374G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909374G
11	47364129	rs121909374G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs121909374G
11	47353677	rs193922384TGCAGACATAGATGCCCCC	T	TGCAGACATAGATGCCCCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922384TGCAGACATAGATGCCCCC
11	47353677	rs193922384TGCAGACATAGATGCCCCC	T	TGCAGACATAGATGCCCCC	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922384TGCAGACATAGATGCCCCC
11	47353677	rs193922384TGCAGACATAGATGCCCCC	T	TGCAGACATAGATGCCCCC	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs193922384TGCAGACATAGATGCCCCC
11	47354740	rs373746463T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373746463T
11	47354740	rs373746463T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 4;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYBPC3;VARIANT_ID=rs373746463T
3	8787288	rs121909280G	C	G	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CAV3,OXTR;VARIANT_ID=rs121909280G
3	8787374	rs28936686A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CAV3,OXTR;VARIANT_ID=rs28936686A
3	8775642	rs116840778A	G	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=CAV3,SSUH2;VARIANT_ID=rs116840778A
7	151257646	rs267606979G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs267606979G
7	151261232	rs267606978G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs267606978G
7	151261232	rs267606978G	C	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs267606978G
7	151257699	rs267606977C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs267606977C
7	151257699	rs267606977C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs267606977C
7	151261289	rs267606976G	A	G	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs267606976G
7	151257696	rs121908991T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908991T
7	151261285	rs121908989A	T	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908989A
7	151265836	rs28938173T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs28938173T
7	151265836	rs28938173T	G	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs28938173T
7	151269750	rs587776643CTAA	C	CTAA	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs587776643CTAA
7	151265887	rs121908988C	T	C	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908988C
7	151273498	rs121908987T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 6;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908987T
7	151273498	rs121908987T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908987T
7	151273498	rs121908987T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908987T
7	151273498	rs121908987T	C	T	.	PASS	PHENOTYPE=FAMILIAL HYPERTROPHIC CARDIOMYOPATHY WITH WOLFF-PARKINSON-WHITE SYNDROME;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=PRKAG2;VARIANT_ID=rs121908987T
17	37821719	rs786205076A	AGG	A	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs786205076A
17	37821719	rs786205076A	AGG	A	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs786205076A
17	37822015	rs104894655T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY 25;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs104894655T
17	37822015	rs104894655T	C	T	.	PASS	PHENOTYPE=PRIMARY FAMILIAL HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but the ACMG/AMP guidelines were not used and there are not relevant GWAS studies;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TCAP;VARIANT_ID=rs104894655T
10	88441437	rs45487699T	C	T	.	PASS	PHENOTYPE=FAMILIAL HYPERTROPHIC CARDIOMYOPATHY 24;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LDB3;VARIANT_ID=rs45487699T
20	30408160	rs121908108A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC MIDVENTRICULAR DIGENIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYLK2;VARIANT_ID=rs121908108A
20	30408136	rs121908107T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC MIDVENTRICULAR DIGENIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYLK2;VARIANT_ID=rs121908107T
3	14183165	rs63750743T	C	T	.	PASS	PHENOTYPE=HYPERTROPHIC CARDIOMYOPATHY;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=TMEM43;VARIANT_ID=rs63750743T
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23894150	LOVDChr14:g.23894150A>G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894150A>G
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23893148	LOVDChr14:g.23893148C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893148C>G
14	23885476	LOVDChr14:g.23885476C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23885476C>T
14	23896866	LOVDChr14:g.23896866C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>T
14	23900677	rs3218713T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713T
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23897792	rs3218715T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218715T
14	23894525	rs3218716T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218716T
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs36211715T
14	23891501	rs45611033A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs45611033A
14	23884618	LOVDChr14:g.23884618T>A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23884618T>A
14	23884461	LOVDChr14:g.23884461C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23884461C>T
14	23884292	LOVDChr14:g.23884292_23884293delinsCA	None	CA	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23884292_23884293delinsCA
14	23882068	LOVDChr14:g.23882068_23882082del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23882068_23882082del
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs36211715T
14	23902912	LOVDChr14:g.23902912_23902914del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23902912_23902914del
14	23901979	LOVDChr14:g.23901979G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901979G>A
14	23901046	LOVDChr14:g.23901046G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901046G>T
14	23901040	LOVDChr14:g.23901040C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901040C>G
14	23901023	LOVDChr14:g.23901023C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901023C>T
14	23901003	LOVDChr14:g.23901003_23901005del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901003_23901005del
14	23900870	LOVDChr14:g.23900870T>A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900870T>A
14	23900847	LOVDChr14:g.23900847G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900847G>C
14	23900831	LOVDChr14:g.23900831T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900831T>C
14	23900794	LOVDChr14:g.23900794A>C^23900796A>G	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900794A>C^23900796A>G
14	23900672	LOVDChr14:g.23900672G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900672G>T
14	23900656	LOVDChr14:g.23900656C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900656C>T
14	23900196	LOVDChr14:g.23900196T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900196T>C
14	23899833	LOVDChr14:g.23899833A>C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899833A>C
14	23899803	LOVDChr14:g.23899803G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899803G>A
14	23899071	LOVDChr14:g.23899071T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899071T>C
14	23899059	LOVDChr14:g.23899059C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899059C>T
14	23898551	LOVDChr14:g.23898551C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898551C>A
14	23898546	LOVDChr14:g.23898546C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898546C>A
14	23898541	LOVDChr14:g.23898541G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898541G>A
14	23898539	LOVDChr14:g.23898539A>G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898539A>G
14	23898525	LOVDChr14:g.23898525_23898527delinsAAC	None	AAC	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898525_23898527delinsAAC
14	23898487	LOVDChr14:g.23898487C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>T
14	23898485	LOVDChr14:g.23898485C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898485C>A
14	23898525	LOVDChr14:g.23898525_23898527delinsAAC	None	AAC	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898525_23898527delinsAAC
14	23898282	LOVDChr14:g.23898282G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898282G>T
14	23898243	LOVDChr14:g.23898243A>G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898243A>G
14	23898222	LOVDChr14:g.23898222T>G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898222T>G
14	23898171	LOVDChr14:g.23898171A>G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898171A>G
14	23897810	LOVDChr14:g.23897810T>A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23897810T>A
14	23897785	LOVDChr14:g.23897785T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23897785T>C
14	23897756	LOVDChr14:g.23897756T>A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23897756T>A
14	23897738	LOVDChr14:g.23897738G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23897738G>T
14	23896922	LOVDChr14:g.23896922T>A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896922T>A
14	23896881	LOVDChr14:g.23896881G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896881G>C
14	23896839	LOVDChr14:g.23896839T>G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896839T>G
14	23896837	LOVDChr14:g.23896837C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896837C>G
14	23896812	LOVDChr14:g.23896812A>T	A	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896812A>T
14	23896898	LOVDChr14:g.23896898_23896899delinsCT	None	CT	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896898_23896899delinsCT
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23895254	LOVDChr14:g.23895254C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895254C>A
14	23895220	LOVDChr14:g.23895220G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895220G>C
14	23895206	LOVDChr14:g.23895206G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895206G>C
14	23895180	LOVDChr14:g.23895180G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895180G>A
14	23895179	LOVDChr14:g.23895179C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895179C>T
14	23895005	LOVDChr14:g.23895005C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895005C>G
14	23894984	LOVDChr14:g.23894984T>G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894984T>G
14	23894969	LOVDChr14:g.23894969C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894969C>G
14	23894968	LOVDChr14:g.23894968C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894968C>G
14	23894612	LOVDChr14:g.23894612C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894612C>G
14	23894593	LOVDChr14:g.23894593T>A	T	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894593T>A
14	23894577	LOVDChr14:g.23894577C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894577C>G
14	23894566	LOVDChr14:g.23894566C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894566C>T
14	23894555	LOVDChr14:g.23894555G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894555G>A
14	23894569	LOVDChr14:g.23894569_23894570delinsTC	None	TC	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894569_23894570delinsTC
14	23894108	LOVDChr14:g.23894108G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894108G>T
14	23894052	LOVDChr14:g.23894052G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894052G>C
14	23894118	LOVDChr14:g.23894118_23894120del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894118_23894120del
14	23894010	LOVDChr14:g.23894010_23894012del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894010_23894012del
14	23893357	LOVDChr14:g.23893357T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893357T>C
14	23893337	LOVDChr14:g.23893337C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893337C>G
14	23893336	LOVDChr14:g.23893336G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893336G>C
14	23893321	LOVDChr14:g.23893321T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893321T>C
14	23893311	LOVDChr14:g.23893311G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893311G>C
14	23893268	LOVDChr14:g.23893268C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893268C>G
14	23893235	LOVDChr14:g.23893235C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893235C>T
14	23893258	LOVDChr14:g.23893258_23893260del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893258_23893260del
14	23893251	LOVDChr14:g.23893251_23893253del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893251_23893253del
14	23891503	LOVDChr14:g.23891503A>G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23891503A>G
14	23891398	LOVDChr14:g.23891398C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23891398C>T
14	23890194	LOVDChr14:g.23890194_23890205del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23890194_23890205del
14	23889376	LOVDChr14:g.23889376A>C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23889376A>C
14	23888469	LOVDChr14:g.23888469G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23888469G>C
14	23887522	LOVDChr14:g.23887522C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23887522C>T
14	23887458	LOVDChr14:g.23887458G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23887458G>A
14	23886825	LOVDChr14:g.23886825G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23886825G>T
14	23886518	LOVDChr14:g.23886518C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23886518C>A
14	23895180	LOVDChr14:g.23895180G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895180G>A
14	23893251	LOVDChr14:g.23893251_23893253del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893251_23893253del
14	23898487	LOVDChr14:g.23898487C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>A
14	23898214	LOVDChr14:g.23898214G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898214G>A
14	23896866	LOVDChr14:g.23896866C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>T
14	23902865	LOVDChr14:g.23902865G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23902865G>A
14	23895179	LOVDChr14:g.23895179C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895179C>T
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898213	LOVDChr14:g.23898213C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898213C>T
14	23898487	LOVDChr14:g.23898487C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>A
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898511	LOVDChr14:g.23898511_23898512insC	None	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898511_23898512insC
14	23902865	LOVDChr14:g.23902865G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23902865G>A
14	23902767	LOVDChr14:g.23902767C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23902767C>T
14	23901979	LOVDChr14:g.23901979G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901979G>A
14	23901922	LOVDChr14:g.23901922C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901922C>T
14	23901865	LOVDChr14:g.23901865T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901865T>C
14	23901040	LOVDChr14:g.23901040C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901040C>G
14	23901040	LOVDChr14:g.23901040C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901040C>G
14	23901048	LOVDChr14:g.23901048G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901048G>C
14	23901046	LOVDChr14:g.23901046G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23901046G>T
14	23900831	LOVDChr14:g.23900831T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900831T>C
14	23900862	LOVDChr14:g.23900862G>T	G	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900862G>T
14	23900794	LOVDChr14:g.23900794A>C^23900796A>G	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900794A>C^23900796A>G
14	23900677	rs3218713T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713T
14	23900677	rs3218713T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713T
14	23900656	LOVDChr14:g.23900656C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900656C>T
14	23900656	LOVDChr14:g.23900656C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900656C>T
14	23900687	LOVDChr14:g.23900687T>G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900687T>G
14	23898525	LOVDChr14:g.23898525_23898527delinsAAC	None	AAC	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898525_23898527delinsAAC
14	23898487	LOVDChr14:g.23898487C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>T
14	23898487	LOVDChr14:g.23898487C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>T
14	23898487	LOVDChr14:g.23898487C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>T
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898488	rs3218714A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218714A
14	23898487	LOVDChr14:g.23898487C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>A
14	23898487	LOVDChr14:g.23898487C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898487C>A
14	23898214	LOVDChr14:g.23898214G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898214G>A
14	23898214	LOVDChr14:g.23898214G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898214G>A
14	23897749	LOVDChr14:g.23897749A>C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23897749A>C
14	23896932	LOVDChr14:g.23896932C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896932C>G
14	23896881	LOVDChr14:g.23896881G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896881G>C
14	23900677	rs3218713T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs3218713T
14	23898223	LOVDChr14:g.23898223T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898223T>C
14	23896866	LOVDChr14:g.23896866C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>G
14	23896866	LOVDChr14:g.23896866C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>T
14	23896866	LOVDChr14:g.23896866C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>T
14	23896866	LOVDChr14:g.23896866C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>T
14	23896866	LOVDChr14:g.23896866C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896866C>T
14	23896837	LOVDChr14:g.23896837C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896837C>G
14	23896043	LOVDChr14:g.23896043G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896043G>A
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23896042	LOVDChr14:g.23896042C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23896042C>T
14	23895255	LOVDChr14:g.23895255G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895255G>A
14	23895189	LOVDChr14:g.23895189C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895189C>T
14	23895189	LOVDChr14:g.23895189C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895189C>T
14	23895180	LOVDChr14:g.23895180G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895180G>A
14	23895180	LOVDChr14:g.23895180G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895180G>A
14	23895180	LOVDChr14:g.23895180G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895180G>A
14	23895179	LOVDChr14:g.23895179C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895179C>T
14	23895023	LOVDChr14:g.23895023G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895023G>A
14	23895023	LOVDChr14:g.23895023G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23895023G>A
14	23894998	LOVDChr14:g.23894998G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894998G>A
14	23894982	LOVDChr14:g.23894982A>C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894982A>C
14	23894969	LOVDChr14:g.23894969C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894969C>G
14	23894969	LOVDChr14:g.23894969C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894969C>G
14	23894969	LOVDChr14:g.23894969C>A	C	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894969C>A
14	23894969	LOVDChr14:g.23894969C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894969C>G
14	23894968	LOVDChr14:g.23894968C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894968C>G
14	23894581	LOVDChr14:g.23894581T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894581T>C
14	23894121	LOVDChr14:g.23894121C>G	C	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894121C>G
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs36211715T
14	23894048	rs36211715T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=rs36211715T
14	23893357	LOVDChr14:g.23893357T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893357T>C
14	23893316	LOVDChr14:g.23893316G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893316G>C
14	23893316	LOVDChr14:g.23893316G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893316G>C
14	23893316	LOVDChr14:g.23893316G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893316G>C
14	23893268	LOVDChr14:g.23893268C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893268C>T
14	23893259	LOVDChr14:g.23893259C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893259C>T
14	23893250	LOVDChr14:g.23893250C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893250C>T
14	23893250	LOVDChr14:g.23893250C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893250C>T
14	23893235	LOVDChr14:g.23893235C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893235C>T
14	23893193	LOVDChr14:g.23893193C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23893193C>T
14	23880498	LOVDChr14:g.23880498_23882876del	None	None	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23880498_23882876del
14	23898213	LOVDChr14:g.23898213C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898213C>T
14	23900847	LOVDChr14:g.23900847G>C	G	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23900847G>C
14	23899785	LOVDChr14:g.23899785T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899785T>C
14	23899071	LOVDChr14:g.23899071T>C	T	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899071T>C
14	23899059	LOVDChr14:g.23899059C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23899059C>T
14	23898464	LOVDChr14:g.23898464C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898464C>T
14	23898267	LOVDChr14:g.23898267A>G	A	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898267A>G
14	23887458	LOVDChr14:g.23887458G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23887458G>A
14	23887453	LOVDChr14:g.23887453C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23887453C>T
14	23898523	LOVDChr14:g.23898523T>G	T	G	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23898523T>G
14	23894612	LOVDChr14:g.23894612C>T	C	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894612C>T
14	23887458	LOVDChr14:g.23887458G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23887458G>A
14	23902865	LOVDChr14:g.23902865G>A	G	A	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23902865G>A
14	23897749	LOVDChr14:g.23897749A>C	A	C	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23897749A>C
14	23894572	LOVDChr14:g.23894572A>T	A	T	.	PASS	PHENOTYPE=CARDIOMYOPATHY HYPERTROPHIC FAMILIAL TYPE 1;INTERPRETATION=ACCEPTED WITH LIMITED EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable but there is not clinical testing;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MYH7;VARIANT_ID=LOVDChr14:g.23894572A>T
